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Bicuspid aortic valve (BAV) is a congenital heart defect, affecting 1-2% of the general 
population. Approximately 30% of individuals with BAV develop ascending aortic 
aneurysm (AscAA). Although the etiology of BAV/AscAA is unknown, previous family-
based studies suggest that BAV is highly heritable. Using whole-exome sequencing, we 
have systematically screened nine patient families, 286 probands, and 193 unrelated 
controls to identify causative variants. ROBO4 is a gene in which we have detected 
multiple independent predicted deleterious alleles showing appropriate familial 
segregation. Targeted sequencing of an additional 441 unrelated probands and 183 
controls detected six additional rare alleles predicted deleterious. Using zebrafish, we 
have established a robust pipeline to functionally evaluate the biological relevance of 
genes/variants implicated in BAV/AscAA. It provides an unprecedented capacity to 
interrogate the cardiovascular structural and functional correlates of BAV/AscAA in 
genetically defined developing and adult zebrafish. First, we establish mutant fish lines 
for selected genes using CRISPR/Cas9 or identify functionally equivalent mutants in 
public resources. For robo4, we generated a 7 base pair deletion in exon six of 19. As 
predicted, this mutation results in nonsense mediated mRNA decay, significantly 
reducing mRNA levels as quantified by qRT-PCR. In order to measure complete cardiac 
function in adult zebrafish, we have optimized two different methods – echocardiography 
and electrocardiography (ECG). We have completed a longitudinal study of wild-type 
zebrafish, establishing normative values for three to eleven months of age for both 
echocardiography and ECG – a critical resource to document genetic predisposition and 
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progression of disease. These data enabled development of a linear model, adjusting for 
the influence of specific parameters such as age, sex, and body size on cardiovascular 
measurements in zebrafish. Furthermore, we were able to apply the newly developed 
echocardiography and ECG methods as well as this linear model to two well-
characterized zebrafish models of arrhythmia as proof-of-principle. Echocardiography of 
robo4 mutants at approximately four to six months reveals extreme outflow turbulence 
and regurgitation (11/41), compared to wild-type fish (4/45). Importantly, our 
echocardiograms from mice homozygous for a Robo4 loss-of-function mutation display a 
similar phenotype. These data establish ROBO4 as a gene critical for the normal 
development and homeostasis of the left ventricular outflow tract and launch a vigorous 
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Chapter 1: Introduction 
 
1.1 Zebrafish as a model organism 
 Zebrafish (Danio rerio) are a valuable model system for the study of 
cardiovascular development and function. Their external fertilization and transparency as 
embryos means development of the zebrafish heart is readily studied, even at the cellular 
level (Stainier & Fishman, 1994). Zebrafish can overcome cardiovascular insults in early 
life, deriving sufficient oxygen exchange via passive diffusion across their small body 
surface to sustain life (Pelster & Burggren, 1996). This allows for the analysis of 
mutations that would be lethal in other organisms. Most importantly, zebrafish cardiac 
electrophysiology closely resembles that of human, despite the fish having a two-
chambered heart rather than a four-chambered heart (Sedmera et al., 2003). Specifically, 
the heart rate of humans and zebrafish are similar (in both development and adulthood) 
(Kopp, Schwerte, & Pelster, 2005; Milan, Jones, Ellinor, & Macrae, 2006). By 
comparison, the heart rate of the adult mouse is about four times faster than that of 
humans’ (Babij, Askew, Nieuwenhuijsen, & Su, 1998; M. P. Lee et al., 2000; Nerbonne, 
2004; Salama & London, 2007). 
 These facts, together with the existence of many mutant lines that have already 
been generated and studied, support the development of zebrafish as a model for human 
cardiac function. Initially, forward genetic screens, using chemical (most commonly 
ENU) mutagenesis to introduce point mutations throughout the genome were performed 
to great success. Dozens of studies have produced a wealth of mutant lines, which 
elucidate the requirement of many genes and pathways in cardiac development 
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(Alexander, Stainier, & Yelon, 1998; Beis et al., 2005; Chen et al., 1996; Chi et al., 2008; 
Stainier et al., 1996; Warren, Wu, Pinet, & Fishman, 2000). The advent of genome 
engineering has further enhanced the power of the zebrafish model, significantly reducing 
the technical challenge of targeted genome manipulation. Many of the studies of the 
resulting mutant zebrafish, however, have focused on the embryonic and larval stages. 
Until very recently, the paucity of high resolution imaging techniques for use in live adult 
zebrafish has precluded more complete studies of their heart anatomy and evaluation of 
cardiovascular function beyond larval stages. In my thesis, I aim to advance and optimize 
the technologies to study the adult zebrafish heart – establishing the use of zebrafish as a 
model organism to examine structural and electrophysiological defects in humans. 
 
1.2 Challenges of studying adult zebrafish 
 Although technologies such as echocardiography and electrocardiography (ECG) 
have been previously implemented in adult zebrafish, their utility has been hampered by 
limited resolution of available apparatus (Milan et al., 2006; L. Sun, Lien, Xu, Shung, et 
al., 2008). For echocardiography, studies have endeavored to document normal and 
mutant adult cardiovascular function using a range of commercially available or custom-
made echocardiography transducers (Kang et al., 2014; J. Lee et al., 2014; Scheid et al., 
2016). Other studies have investigated age-related changes in the heart, recovery of the 
heart after cryo-injury, and cardiac responses to temperature changes via 
echocardiography (Hein et al., 2015a; L. Lee et al., 2016; Y. Sun, Fang, Xu, Lu, & Chen, 
2015). Previous electrocardiography studies on adult fish, although capturing consistent 
ECG traces, require perfusion and the fish is sacrificed, preventing longitudinal studies 
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(Milan et al., 2006). Most of these studies, however, predate the availability of 
contemporary high-frequency probes, ECG machines, and advanced equipment for 
analysis. Further, previous analyses failed to fully account for principal components of 
inter-fish variation - physical parameters such as age, sex, body length, body width, and 
body weight. My work optimizes echocardiography and ECG for use with zebrafish of 
different ages, sizes and phenotypes, while determining the factors that need to be 
adjusted for to develop the most biologically accurate models for future analysis. 
 
1.3 Adult zebrafish cardiac anatomy and electrophysiology 
 Historically, zebrafish have been utilized as a model for embryonic development. 
Recently, studies have focused on adult zebrafish where understanding the adult zebrafish 
heart anatomy and physiology is key. Unlike mammalian hearts, the adult zebrafish heart 
consists of two heart chambers, an atrium and a ventricle, and a structure analogous to the 
aorta -- the bulbus arteriosus (Hu, Joseph Yost, & Clark, 2001) (Figure 1-1). The sinus 
venosus, similar to the mammalian vena cava, collects deoxygenated blood that flows 
into the atrium, through the atrioventricular valve, and then into the ventricle (Figure 1-
1). The atrium has a very thin muscular wall and thin trabeculae within the lumen. 
Interestingly, the atrium has a significant pumping function, playing a much larger role in 
pumping than in humans. In fact, in zebrafish, the atrium provides a strong atrial kick to 
move blood into the ventricle rather than relying on a pressure gradient, as in humans. 
The ventricle is thicker than the atrium and has numerous trabeculae. Blood flows from 
the ventricle through the bulboventricular valve into the bulbus arteriosus. The bulbus 
arteriosus works as a capacitor to maintain blood through the fish. Similar to the human 
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aorta, the bulbus arteriosus is made up of three tissue layers: the endothelial (intima), 
media, and externa (Hu et al., 2001). Importantly, the media is made up of smooth muscle 
cells and an intricate network of collagen and elastin fibers. The cell-makeup of the 
zebrafish heart and bulbus arteriosus is similar to the human heart and aorta, suggesting 
the disease pathogenesis of interest in humans could be modeled in the zebrafish. Finally, 
blood flows from the bulbus arteriosus into the ventral aorta and then to the gills for 
oxygenation. Echocardiography allows us to visualize each chamber of the heart and the 
bulbus arteriosus as well as blood flow patterns and velocities. Measurements of the 
chambers are the same as the measurements of the human heart chambers. The blood 
flow patterns in zebrafish are almost identical to the human blood flow patterns through 
the mitral valve and the aortic valve, while keeping in mind the strength of the zebrafish 
atrium compared to the ventricle.	  
 The electrophysiology of zebrafish and humans are also remarkably similar 
(Sedmera et al., 2003). The propagation of action potentials (AP) in zebrafish, like 
humans, starts with the sinoatrial node between the sinus venosus and atrium. It travels to 
the atrium and then slows down before reaching the atrioventricuar node. At the 
ventricle, contraction occurs from the apex to the base. This AP can be visualized in a 
diagram with four phases, where electrical charge (mV) on the y-axis and time on the x-
axis. The AP begins with a resting membrane potential of -90 mV and then rapidly 
depolarizes (phase 0). The membrane potential quickly spikes to +20 mV. Next, there is a 
slight repolarization during phase 1. From there the AP is lengthened and the AP plateaus 
at around +15mV. In the third phase, there is rapid repolarization to -90 mV. Finally, the 
resting membrane potential is restored and this is maintained until the next AP. This 
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action potential results in the contraction of the heart and can be monitored using 
electrocardiography (ECG). Finally, the human heart rate is around 60 to 100 beats per 
minute with an ECG cycle of around 1 second (I. U S Leong, Skinner, Shelling, & Love, 
2010). 
 To model disease, mice have typically been used due to the fact that they are 
small, fast breeding mammals with a high fecundity. When studying cardiac function, 
however, mice are less than optimal. Mice have a heart rate around 310 to 480 beats per 
minute. The ECG cycle for mice is around 0.1 second and most importantly, mice have a 
different action potential and a very different electrocardiogram compared to humans 
(Figure 1-2).	  Zebrafish as a model organism for cardiac diseases, comparatively, have a 
heart rate of about 100 to 130 beats per minute depending on age with an ECG cycle of 
around 0.4 seconds (Figure 1-3). And finally, the zebrafish action potential is almost 
identical to human with a sharp depolarization followed by a large plateau, before 
repolarization (I. U S Leong et al., 2010). This leads to an almost identical ECG trace 
between zebrafish and humans (Figure 1-3). The similarities between zebrafish and 
human heart biology, particularly in comparison with mice heart biology, leads us to 
believe zebrafish is a great model organism to not only use for embryonic studies, but 
also adult studies. 
 
1.4 Development of tools to study adult zebrafish hearts 
 In this investigation we undertake a longitudinal echocardiographic and ECG 
studies of adult zebrafish. Using a high frequency (70 MHz) transducer, we capture high-
resolution, real-time documentation of the structural integrity of the two-chambered heart 
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and the bulbus arteriosus. It also allows evaluation of functional integrity via analyses of 
heart rate (HR), blood flow velocity through the atrioventricular (AV) and 
bulboventricular (BV) valves, isovolumetric relaxation and contraction times (IVRT and 
IVCT), velocity time integral (VTI) through the AV and BV valves, ventricular ejection 
time (VET), and a variety of other anatomical and physiological measurements for 
analysis. Concurrent with these echocardiographic analyses, we document the cardiac 
conductance characteristics of zebrafish. ECG analysis was performed with the iWorx 
Zebrafish ECG Recording and Analysis System, designed specifically for zebrafish, to 
capture accurate electrical activity of the adult zebrafish heart. 
 We followed two groups of fish over a three-month period measuring 
echocardiography and ECG measurements in all fish in both groups for three consecutive 
months. The early-life adult (ELA) zebrafish were measured at ages three, four, and five 
months, and mid-life adult (MLA) zebrafish were measured at months nine, ten, and 
eleven. We next determined which measurements and parameters are correlated amongst 
the echocardiographic and ECG measurements. These measurements and parameters 
should be adjusted for in order to properly analyze all echocardiography and ECG data. 
From these correlation analyses, we determined a linear model to account for multiple 
measurements from each fish and adjust for appropriate covariates to accurately correct 
for the effect of age, sex, and body size parameters on our cardiovascular measures of 
interest as well as the random effects due to date of acquisition for both echocardiography 
and ECG. We demonstrate that failure to properly account for physical parameters as 
covariates can lead to erroneous identification of differences between zebrafish cohorts. 
This analysis of wild-type fish provides a guide for how to properly perform 
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echocardiography and ECG on zebrafish, and also establishes normal values for wild-
type fish of ages that are commonly used in the laboratory setting. It should be noted that 
due to the high genetic diversity in zebrafish (an outbred model organism), each 
laboratory must conduct their own studies with their in-house zebrafish to establish 
baseline measurements for their facility. Taken together our data establish a robust 
strategy for non-terminal echocardiography and ECG in zebrafish, which I then applied 
to various mutant lines. 
 
1.5 Application of echocardiography and ECG techniques 
 To validate the utility of these techniques and the value of adjustments for body 
size, we evaluated previously described models of arrhythmias and long QT syndrome in 
zebrafish, resulting from mutations in the kcnh6a gene (R Arnaout et al., 2007; 
Langheinrich, Vacun, & Wagner, 2003). kcnh6a encodes a voltage-gated potassium 
channel that is required for normal repolarization of ventricular action potentials. The 
human orthologous gene for kcnh6a is KCNH6, as determined by conserved genome 
location (synteny) and amino acid sequence comparison (Ivone Un San Leong, Skinner, 
Shelling, & Love, 2010). Although little is known about defects in the human KCNH6, 
mutations in the paralogous and structurally highly related human KCNH2 cause around 
45% of cases of autosomal dominant long QT syndrome (Sehnert & Stainier, 2002; 
Splawski et al., 2000). Adult heterozygote kcnh6as290 zebrafish have delayed ventricular 
repolarization and the reported QT interval detected by terminal ECG is significantly 
longer than in wild-type fish. Homozygosity for this allele is lethal (R Arnaout et al., 
2007). Evaluation of adult heterozygote kcnh6as290 zebrafish in our pipeline confirms a 
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clear arrhythmia by ECG with longer PR, QRS, and QT intervals. By echocardiography, 
heterozygote kcnh6as290 mutants demonstrate significantly decreased velocity time 
integrals (VTI) through the AV valve. Another mutant allele, kcnh6atb218, has been 
previously characterized with a 2:1 AV block embryonically and with long QT as adults 
(Kopp et al., 2005; Meder et al., 2011). In our evaluation of adult kcnh6atb218 
homozygotes we detect no significant electrophysiological differences compared to wild-
type zebrafish. By echocardiography, they also do not show any structural or flow 
differences. These studies demonstrated the pipeline was working and ready for analysis 
of candidate genes for diseases of interest. 
 
1.6 Bicuspid aortic valve with and without ascending aortic aneurysm 
 Bicuspid aortic valve (BAV) is the most common congenital heart defect, 
affecting 1-2% of the population. These individuals, instead of having an aortic valve 
with 3 leaflets, have only 2 leaflets. BAV is associated with ascending aortic aneurysm 
(AscAA) and dissections of the aorta (Braverman et al., 2005). BAV does not cause 
aneurysm of the aorta. For example, patients with BAV can undergo valve replacement 
surgery and still develop aneurysm of the aorta (Braverman et al., 2005). Furthermore, 
members of patient families often demonstrate variations of isolated BAV, BAV with 
AscAA, and AscAA (Loscalzo et al., 2007). Overall, patients with BAV have a 9x risk of 
a dilated aorta (Larson & Edwards, 1984). This risk begins at a younger age than in 
individuals without BAV and increases with age (Larson & Edwards, 1984). Unlike 
Marfan syndrome (MFS), which also presents with thoracic aortic aneurysm, aortic 
dilatation in patients with BAV presents in the ascending aorta rather than the sinuses of 
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Valsalva (aortic root), more similar to what is seen in patients with Loeys-Dietz 
syndrome (LDS) (Dore, Brochu, Baril, Guertin, & Mercier, 2003). Patients with LDS, 
however, rarely present with isolated dilatation of the ascending aorta (without bicuspid 
aortic valve). 
 Studies have shown that BAV is highly heritable (heritability of 89%) (Cripe, 
Andelfinger, Martin, Shooner, & Benson, 2004). It is an autosomal dominant disorder, 
with a 3:1 male predominance and incomplete penetrance (Loscalzo et al., 2007). 
Interestingly, similarly to both MFS and LDS, reduced fibrillin-1 and increased TGF-β 
signaling have been determined in patients with BAV with and without AscAA. Other 
genes/pathways implicated in BAV with and without AscAA from numerous human 
studies include NOTCH1 (Garg et al., 2005; McKellar et al., 2007), SMAD6 (Tan et al., 
2012), ACTA2 (Guo et al., 2007), MYH11 (L. Wang et al., 2010), and  mouse studies 
including GATA5 (Laforest et al., 2011) and eNOS (T. C. Lee, Zhao, Courtman, & 
Stewart, 2000). Despite the similarly seeming disease pathogenesis with other diseases of 
aneurysm and the various studies on BAV, the genetic etiology and disease mechanism 
underlying BAV and associated aneurysm is still unknown. Likely obstacles to studying 
BAV and aneurysm include extreme locus heterogeneity (Martin et al., 2007), variable 
expressivity (Loscalzo et al., 2007), and the confounding influence of incomplete 
penetrance, sex bias, and environmental and/or genetic modification of disease onset and 
severity. The McCallion lab is in a larger consortium that is working to determine some 
causes of BAV and associated aneurysm. Specifically, we have used zebrafish as a cost-
effective model organism with which to study potential candidate genes for BAV with 




1.7 Roundabout 4 (ROBO4) 
 With the consortium I examined multiple candidate genes in zebrafish, ROBO4 is 
the most complete story. In 2002, Huminiecki et al. found a new member of the 
roundabout family (ROBO) called magic roundabout or ROBO4 (Huminiecki, Gorn, 
Suchting, Poulsom, & Bicknell, 2002). ROBO4 was determined to be expressed in 
endothelial tissue and to encode a 107 kD protein. The protein, unlike other members of 
the roundabout family, contains only 3 immunoglobulin and 2 fibronectin domains in its 
extracellular region. This is compared to five immunoglobulin and 3 fibronectin domains 
in both ROBO1 and ROBO2. ROBO3 is similar to ROBO4 in that it also uniquely differs 
structurally from the other members of the ROBO family. Other relevant regions of the 
ROBO4 protein include an N-terminal signal peptide, four N-glycosylation sites within 
the extracellular domain, a transmembrane region, and a proline-rich region within its 
intracellular domain. 
 Members of the roundabout family have typically been associated with Slit-Robo 
signaling, which is involved with axon repulsion in the developing nervous system. 
However, ROBO4 has consistently been shown to be involved with angiogenesis and the 
development of blood vessels, specifically in endothelial tissue. In 2005, Bedell et al. 
demonstrated, in zebrafish embryos, that robo4 is expressed in the endothelial tissue, the 
dorsal aorta, posterior cardinal vein, and intersomitic vessels (Bedell et al., 2005). 
Morpholino knockdown studies showed the loss of intersomitic vessels in morphant 
zebrafish. The loss of robo4 was compensated for when human ROBO4 coding sequence 
was injecting alongside the morpholino, suggesting evolutionary conservation. In vitro 
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studies by Jones et al. showed that ROBO4 is vital for blood vessel permeability and loss 
of ROBO4 leads to increased vascular leakage and decreased cell barrier integrity (Jones 
et al., 2008). ROBO4 function is still under debate, specifically its role in Slit signaling. 
There has been numerous studies suggesting that ROBO4 binds to Slits (Enomoto et al., 
2016; Fritz et al., 2015; Jones et al., 2008; Yu et al., 2014), but there is also data against 
this, suggesting ROBO4 binds to UNC5B (Koch et al., 2011). Regardless, Mommersteeg 
et al. recently showed valve defects in knockout mice for Robo1 and Robo2 or Slit3. No 
studies looked at ROBO4. Although the exact mechanism of ROBO4 is still being 
explored, from this literature, ROBO4 seemed to be a good candidate to move forward 
with for studies of BAV with and without AscAA.  
12
1.8 Figures 
Figure 1-1. Zebrafish have a two-chambered heart. The zebrafish heart is made up the 





























Figure 1-2. Mouse cardiac electrophysiology exhibit major differences to human cardiac 
electrophysiology. The action potential and ECG cycle between mice and humans are 













Figure 1-3. Zebrafish cardiac electrophysiology is similar to human cardiac 
electrophysiology. The action potential and ECG cycle between zebrafish and humans are 




Chapter 2: Development of echocardiography for adult zebrafish 
 
2.1 Introduction 
 Although the adult zebrafish heart should have great potential as a tool for studies 
of cardiovascular development, structure and function, the utility of this model system 
has been limited by the small size of its heart, approximately one millimeter in length (Hu 
et al., 2001). It has therefore been challenging to image adult zebrafish heart structure and 
function in vivo at high resolution. To address this challenge, we set out to capture high-
quality images of the small adult zebrafish heart, using high frequency ultrasound at 70 
MHz. In this chapter, I optimize the procedure. For each aspect of the procedure, a 
standard operating procedure was written. First, the anesthetic was decided. Commonly 
in zebrafish studies, tricaine (MS-222) is used as a general anesthesia for genotyping. In 
ECG studies, a paralytic is used to minimize gill movement. In order to provide the most 
biologically relevant data, without disrupting the normal breathing patterns of the 
zebrafish, tricaine was used. A paralytic was used during optimization, but the fish did 
not survive the procedure (data not shown). Position of the transducer on the fish, 
duration of the echocardiography session, and finally orientation of fish in the trough 
were all optimized to capture all heart chambers and blood flow between chambers. Due 
to the goal of our studies (specifically the outflow tract), positioning was adjusted to 
focus on the bulbus arteriosus and the ventricle rather than the atrium. Finally, to 
maximize both resolution and viability of each assayed fish, the amount of gel on the fish 
was optimized. Only a half-centimeter deep of gel is placed on the transducer, which is 
then lightly placed onto the fish. This provides the highest resolution of images. We also 
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tried placing the fish in a conical of water and placing gel on the conical, but the 
resolution was quite poor (data not shown). 
 After the echocardiography protocol was improved, we captured 
echocardiography measurements on 20 wild-type (AB) fish total for two different three-
month longitudinal studies. Of the 20 fish, two different groups were studied (ten in each 
group). The two groups were broken up by age – young adult and mid-life adults, 
encompassing most time points commonly used in the laboratory setting. Using 
measurements from this study (60 echocardiographic studies total), we were able to 
determine the best method by which to model the data accurately. This includes which 
parameters to incorporate as covariates and random effects. Currently zebrafish groups 
working on echocardiography are not adjusting or controlling for size of the fish when 
measuring the heart (Hein et al., 2015b; Kang et al., 2014; J. Lee et al., 2014; L. Lee et 
al., 2016; Scheid et al., 2016; L. Sun, Lien, Xu, & Shung, 2008; Y. Sun et al., 2015; L. 
W. Wang et al., 2017). In this chapter, I explain that specific measurements and 




2.2.1 Establishing a protocol for echocardiography 
 We designed a clay mold to hold individual fish, which was sized to each fish. 
The mold with the fish was placed inside a larger trough, filled with zebrafish facility 
water containing the anesthetic MS-222 (Figure 2-1a). The zebrafish are placed in the 
trough, dorsal side down (ventral surface upwards). The fish is submerged in the 
anesthetic solution in order to maintain oxygen circulation, leaving its ventral surface 
exposed. A thin layer of ultrasound gel is placed on the transducer. The gel increases 
image quality immensely and, used sparingly, showed no negative effects on the fish. 
 In our hands, the highest quality imaging of the atrium, ventricle, and bulbus 
arteriosus in a single plane was obtained from sagittal long axis views (LAX) using B-
Mode imaging (Figure 2-1b). The probe is placed directly onto the ventral side of the 
fish. In this way, we were able to capture measurements pertaining to the ventricle and 
the bulbus arteriosus. Atrial measurements were not captured due to the difficulty in 
visualizing the chamber (Figure 2-1b). Due to the highly trabeculated nature of the 
ventricle, the epicardial surface of the ventricle was traced for measurements rather than 
the endocardial edge as done in clinical studies. In systole and diastole, we calculated 
ventricular diastolic and systolic areas and volumes (Figure 2-1c, d). From these 
measurements, stroke volume (SV), ejection fraction (EF), and fractional shortening (FS) 
were calculated. The diameter of the bulbus arteriosus was measured using the aortic arch 
function while in ventricular systole (Figure 2-1d). The diameter is measured at the 
widest section of the bulbus arteriosus while still remaining parallel with the ventricle. 
After B-Mode imaging was concluded, color Doppler mode was used to determine 
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location and direction of blood flow through the heart. The red flow is towards the 
ultrasound transducer and blue is flow away. Flow from the atrium into the ventricle is 
away from the probe and can be seen in red (Figure 2-1e). Blood flow from the ventricle 
into the bulbus arteriosus is toward the probe and can be seen in blue (Figure 2-1f). While 
in LAX and color Doppler mode, PW Doppler was used to display the sample volume 
overlay on the color Doppler mode image. The sample volume wireframe was moved in 
order to acquire blood velocity measurements from the AV valve, over the red flow in 
color Doppler mode (Figure 2-1e). Cine loops were captured and used to calculate early 
(E) and late (A) atrial diastolic filling velocities, velocity time integral through the AV 
valve (AV VTI), isovolumetric contraction time (IVCT), and isovolumetric relaxation 
time (IVRT) (Figure 2-1g). It should be noted that in zebrafish the A peak is taller than 
the E peak. This is opposite of what is seen in humans for flow across the mitral valve. 
This is because of the strong pumping power of the atrium during ventricle filling in 
zebrafish. 
 Next, the wireframe was moved to acquire blood velocity measurements through 
the BV valve and the ventricular outflow tract (VOT), which should appear blue in color 
Doppler mode (Figure 2-1h). The captured trace was then used to calculate the heart rate 
(HR), mean and peak outflow velocities through the VOT, velocity time integral (VTI), 
and ventricular ejection time (VET) (Figure 2-1h). For optimal fish anesthetic recovery, 
imaging sessions lasted no longer than 10 minutes. The E/A ratio was determined by 
using the E and A velocities to determine diastolic function. The Tei index (myocardial 
performance index) was calculated from (IVCT+IVRT)/(VET). The cardiac output was 




2.2.2 Determining biological covariates for echocardiography data 
 Despite the technological advances in the capacity to record echocardiography, 
we are very aware that analyses of cohorts of fish may be impeded by first, noise that 
results from genetic variation within a population, second, covariates in age, sex, body 
size/volume/mass parameters much like the human population and finally, from technical 
variation arising. We set out to collect data from two cohorts of zebrafish representing 
two age intervals: early-life adult (ELA) and mid-life adult (MLA) fish. For the ELA 
cohort, measurements were taken once a month at three months, four months, and finally, 
five months of age (Table 2-1). Thus, this longitudinal study included measurements 
acquired at three time points for each ELA zebrafish. Similarly, for the MLA cohort, we 
took measurements at nine, ten, and 11 months of age (Table 2-2). These time points 
were chosen because these are commonly used for laboratory fish. It should be noted that 
the ELA and MLA cohorts are two different sets of fish and not the same fish. For each 
set of measurements, individual fish underwent echocardiography, and were returned to a 
tank for recovery. Fish were maintained in individual tanks to avoid the risk of “sample 
switching” and to control for food intake. Food intake can greatly affect the size of the 
individual fish and by keeping the fish by itself the competition for food is removed. 
Once these data were collected, we then evaluated how best to analyze these age data 
with respect to the working hypothesis that the size of the fish could affect the size of the 
heart and this must be adjusted for in analysis of the heart. 
 
2.2.3 Age and sex affect the size of zebrafish 
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 Next, we determined the effect of one of the major variations between fish – size. 
Common observation shows that the older the fish, the bigger the fish and that female 
fish are larger than male fish, but no groups have published these data plainly. This 
observation is compounded by the fact that the fish community says that overcrowded 
tanks of zebrafish results in smaller fish overall, but also a skewed proportion of male 
fish to female fish in the tank. Looking at body weight in grams as a measure of body 
size at three time points (three, four, and five months of age), we see that individual fish 
get larger over time (**P < 0.01, Figure 2-2). In order to best control for the growth of 
individual fish, particularly between studies, fish should be maintained in individual 
tanks starting at maturity. Under these conditions and using body weight as a measure of 
size, we determined that female fish are consistently larger in size compared to male fish 
(Figure 2-3, *P < 0.05). This is logical since female fish are often gravid with eggs, 
making them larger. Even non-gravid female fish are often larger than males. Both gravid 
and non-gravid fish were used in this study. From these two tests, we determined that age 
and sex of zebrafish matter in size of the fish and are two covariates that must be adjusted 
for in analysis. 
 
2.2.4 Body size parameters affect echocardiography measurements 
 Next, to determine more covariates that affect the data, we generated a correlation 
plot for all echocardiographic data. This plot describes the relationship between 
anthropometric parameters and all measured traits. To generate this plot and analysis, 
each parameter and echocardiographic measurement was plotted against all other traits 
and itself (Figure 2-4). For each trait-trait pair, a correlation relationship was determined 
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and shown visually by a colored dot (either blue or red for direct or anti-correlation, 
respectively). The stronger the correlation, the dot for each trait-trait pair is darker in 
color and the larger in size. As seen in Figure 2-4, sex was not included in the analysis 
since our previous analysis showed that sex affects size (Figure 2-2 and Figure 2-3). 
 For measurements determined via echocardiography, the correlation plot reveals 
that body size parameters including body length, width and body weight are each highly 
correlated with the majority of measurements (Figure 2-4). In particular, anatomical 
measurements such as the diameter of the bulbus arteriosus, the area and volume of the 
ventricle in both systole and diastole, and measurements such as SV, cardiac output, and 
blood flow velocity through the BV valve (mean and peak) were directly correlated with 
these parameters. Early filling velocity (E) was highly anti-correlated. Body length, 
width, and body weight were all highly correlated with one another, as expected. As 
illustrated by this plot, body size parameters are clearly correlated with most of the 
echocardiographic measurements. These parameters become very important when 
comparing measurements between groups of individuals by echocardiography. 
 
2.2.5 Failure to adjust for body size parameters results in inaccurate results 
 This importance can be clearly seen when we look at the diameter of the bulbus 
arteriosus during systole, as an example of the effect of size on analysis, results, and 
conclusions. The diameter of the bulbus arteriosus is a simply determined by measuring 
across the bulbus ateriosus, from one side to the next. Since this bulbus arteriosus is 
conical this measurement is a diameter. The diameter of the bulbus arteriosus is strongly 
positive correlated with body size parameters (body weight, length, and width) as 
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determined by the correlation plot analysis (Figure 2-4). As seen in the top panel of 
Figure 2-5, the measurement of the diameter of the bulbus arteriosus (y-axis) increases 
with the size of the fish, shown here by body weight in grams. We can see this 
relationship by a regression analysis, with an R2 value of 0.32. This means that around 
32% of the variance in the diameter of the bulbus arteriosus is predicted by the size of the 
individual fish. This proportion shows a clear relationship between diameter of the bulbus 
arteriosus and body size. Thus, the data needs to be adjusted for size. When the residuals 
of the measurements of the diameter of the bulbus arteriosus are regressed against body 
size, the R2 value decreases to 0.018 (bottom panel, Figure 2-5). This means that if body 
size is adjusted for, the proportion of the variance in the diameter that is predicted by the 
size of the fish decreases from 32% to 1.8%. From this regression analysis it is clear that 
body size parameters need to be adjusted for because failure to adjust for size could lead 
to inaccurate conclusions. For example, if we have two fish: a wild-type fish and a 
mutant fish and the mutant fish are larger than the wild-type fish, comparison of the two 
values for diameter of the bulbus arterious will indicate that the mutant fish has a larger 
diameter. This could lead incorrectly to the conclusion that the mutant fish have 
aneurysm in comparison to wild-type fish. Furthermore, adjusting for size provides the 
most accurate data set for the most accurate analysis. Although this a specific example, 
the correlation plot from Figure 2-4 shows that most of the echocardiographic 
measurements must be adjusted for size. 
 
2.2.6 Adjusting for body size parameters removes correlations 
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 The strong effect of size on the diameter of the bulbus arteriosus can be observed 
in a majority of echocardiographic measurements (Figure 2-4). The strongest positive 
correlations with body size are echocardiographic traits that are measurements of the 
heart chambers (ventricle area and volume in systole and diastole), stroke volume (which 
is dependent on size of the ventricle), and cardiac output (which is calculated from stroke 
volume). Figure 2-4 shows velocity through the outflow tract and the A peak inflow 
velocity is positively correlated with size as well, but to a lesser extent. The strongest 
anti-correlation with body size parameters is the E peak velocity. These correlations need 
to be removed and body size needs to be adjusted for. We re-determined the correlations 
between all echocardiographic traits and measurements, adjusting for body size 
parameters, by performing correlation analysis on the residuals of the measurements 
(Figure 2-5). Correlations seen previously without adjustment are now corrected. The 
circles that mark correlations between, for example, diameter of the bulbus arteriosus and 
the body size parameters are now gone. The adjustment for body size parameters now 
allow us to see true correlations in the data such as the diameter of the bulbus arteriosus 
and outflow tract velocity. 
 As mentioned earlier, sex and body size are related. Sex was not included in the 
correlation analysis because it is a binary trait and the effects of sex on size are included 
in the correlation analysis. We did perform correlation analysis, including adjustment for 
body size, on females alone (Figure 2-6) and males alone (Figure 2-7). These plots show 
the correlations between different echocardiographic measurements in both females and 
males. These differences in correlations between echocardiographic measurements in 
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females and males are not unexpected, but show that male and female fish should be 




 In light of our conclusions from the data correlation analyses, we proceeded to 
establish a linear mixed effects model to adjust for the traits and parameters shown to 
affect echocardiographic measurements – age, sex and body size parameters. A linear 
regression model is a statistical analysis often used for data that is grouped in a 
hierarchical structure. In the echocardiography data, ages, time points, sex were 
considered groups within the data. Furthermore, from the correlation analysis, we needed 
to adjust for specific parameters or covariates. Each covariate added systematically into 
the final model and each model was compared using ANOVA, confirming the covariate 
changed the model in statistically significant manner. The final covariates included were 
group (which will be genotype in future studies), type (mutant line or AB lines for future 
studies), age, sex, and body size parameters (body weight, body length, and body width). 
These covariates are all fixed effects. The final covariate is date of echocardiography, as 
a random effect. Due to the nature of the protocol for echocardiography, the transducer 
set-up differs for each session of echocardiography. This change can affect the readings 
and cause batch effects. To control for this, date of echocardiography was included as a 
random effect. The protocol for reading the echocardiograms (taking the measurements) 
is not set-up dependent and therefore was not included in the final model. The final 
model for all future analysis is: lmer(trait) ~ group + type + body weight + body length + 




2.4.1 Zebrafish maintenance. All adult (three months and older) wild-type (AB) 
zebrafish lines were maintained in system water according to standard methods28. Animal 
upkeep and experimental procedures were in accordance with the ethical permits set by 
the Johns Hopkins Institutional Animal Care and Use Committee. 
 
2.4.2 Echocardiography. To capture high-resolution images, the Vevo 2100 Imaging 
System equipped with a 70 MHz ultrasound transducer was used (VisualSonics®, 
Toronto, ON, Canada). The following settings were used for all reported zebrafish 
echocardiography sessions: imaging frequency, 50 MHz for B-Mode, 40 MHz for 
Pulsed-Wave (PW) Doppler and color Doppler, 10-20 Hz pulse repetition frequency, 
adjusted as necessary, 30-35 Db Doppler gain, 200 frames per second in B-mode, and 7 
mm image depth. The zebrafish (n=10 per group) were anesthetized by placing the fish 
into a plastic cup filled with 100 ml of 168 µg/ml MS-222 (tricaine methane sulfonate). 
Stage 3-anesthesia (loss of equilibrium, decreased opercular movement rate, no voluntary 
locomotion, non-responsive to stimuli) was obtained prior to imaging and maintained 
throughout the period of data recording. Fish were weighed and measured for width and 
length and then stabilized in the clay mold within the plastic trough filled with MS-222, 
leaving only the most ventral surface of the ventrum exposed. A thin layer of Parker 
Aquatic 100 ultrasound gel was then applied to the transducer array (2-3 mm) using a 




 The transducer probe was positioned in a vertically within the manipulator with 
the notch facing caudally, meaning the transducer surface lies longitudinally over the 
ventrum of the fish along the anterior-posterior axis. Thus, the ultrasound beam is thus 
perpendicular to the long axis of the fish. The transducer was lowered towards the fish 
until it makes contact with the gel and the heart is visualized in B-Mode. Touching the 
transducer to the surface of the fish will distort the signal. Two-dimensional B-Mode 
imaging was used to obtain videos of the heart, including ventricle, atrium, and bulbus 
arteriosus, in long axis view. These 100 frame cine loops were then analyzed using the 
Vevo Lab Software cardiac package. 
 The left ventricular trace function was used to trace the epicardial surface of the 
ventricle in systole and diastole, calculating ventricular systolic and diastolic areas and 
volumes, stroke volume (SV), ejection fraction (EF), and fractional shortening (FS). The 
diameter of the bulbus arteriosus was measured using the aortic arch function while in 
ventricular systole. Color Doppler mode was used to determine location, direction, and 
velocity of blood flow through the heart. While in long axis view and color Doppler 
mode, PW Doppler mode was used to display the sample volume overlay on the color 
Doppler mode image. The sample volume wireframe was moved in order to acquire 
velocity measurements from the ventricular outflow tract (VOT), which should appear 
blue in color Doppler mode. The Doppler angle was adjusted to align the yellow gate as 
parallel as possible to blood flow through the VOT. Cine loops were captured as desired 
and analyzed to calculate the heart rate (HR), mean and peak outflow velocities through 
the VOT, velocity time integral (VTI), and ventricular ejection time (VET). Next, the 
wireframe was moved to acquire velocity measurements through the atrioventricular 
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(AV) valve, which should appear red in color Doppler mode. Cine loops were captured 
and used to calculate early (E) and late (A) diastolic filling velocities, AV VTI, 
isovolumetric contraction time (IVCT), and isovolumetric relaxation time (IVRT). The 
Doppler angle was adjusted to align the yellow gate as parallel as possible to the flow of 
blood through the AV valve and cine loops were captured. The Tei index, also known as 
the myocardial performance index, was calculated from (IVCT+IVRT)/(VET). The 
cardiac output was calculated from SV multiplied by HR. The fish were removed from 
the imaging trough and placed in a cup of fresh room temperature aquarium water to 
facilitate recovery from anesthesia. To ensure optimal recovery, imaging sessions lasted 
no longer than 10 minutes. Evaluated zebrafish were then returned to individual tanks to 
recover. 
 
2.4.3 Statistical Analysis. For experiments including multiple comparisons, P values 
refer to one-way ANOVA. For experiments including only one comparison, P values 
refer to unpaired two-tailed Student’s t-test or two-tailed Welch’s t-test. Means with 
ranges are shown. P values less than 0.05 were considered significant. Correlation plots 
were generated using the corrplot() package in R version 3.2.3. A linear mixed effects 
regression model estimated the effect of group on mutation status. Age, sex, body size 
parameters, and type were included as covariates with date of echocardiography as a 
random effect: lmer(trait) ~ group + type + body weight + body length + body width + 




2.5 Tables  
 
Parameters and Measurements Mean (range) ELA 1  
Mean (range) 
ELA 2  
Mean (range) 
ELA 3 
AV Measurements    
Early (E) Diastolic Filling (mm/s) 21.48 (10.94-28.17) 15.37 (10.94-21.88) 21.45 (14.29-27.34) 
Late (A) Diastolic Filling (mm/s) 92.07 (49.22-135.6) 129.6 (57.42-218.6) 136.2 (39.59-275.6) 
E/A 0.2687 (0.1053-0.4545) 0.1353 (0.07353-0.2857) 0.2258 (0.06349-0.6154) 
Velocity Time Integral (mm) 8.095 (5.093-11.74) 8.396 (5.592-11.96) 10.8 (5.642-25.95) 
IVCT (ms) 28 (15-45) 26.5 (20-40) 29.5 (25-40) 
IVRT (ms) 74.13 (35-105) 58.58 (35-95) 60.1 (23.3-137.5) 
    
BV Measurements    
Heart Rate (bpm) 70.9 (50-90) 68.4 (37-101) 77 (58-96) 
BV Mean Velocity (mm/s) 51.54 (21.37-102.2) 75.95 (58.2-107.2) 53.72 (28.86-101.8) 
BV Peak Velocity (mm/s) 88.65 (33.56-177) 131.5 (97.45-184.1) 95.15 (49.98-194.9) 
Velocity Time Integral (mm) 10.07 (4.578-21.35) 14.29 (8.662-21.55) 10.59 (4.565-22.06) 
Ventricular Ejection Time (ms) 172.5 (155-195) 154 (90-185) 157.5 (130-185) 
    
Ventricular and BA Measurements    
Systolic Area (mm2) 0.6872 (0.226-1.282) 0.8644 (0.665-1.41) 0.9077 (0.667-1.157) 
Diastolic Area (mm2) 1.054 (0.336-1.766) 1.349 (0.923-1.93) 1.31 (0.874-1.744) 
Systolic Volume (mm3) 0.4769 (0.179-0.938) 0.5868 (0.359-1.087) 0.6058 (0.351-0.819) 
Diastolic Volume (mm3) 0.7748 (0.14-1.617) 1.108 (0.583-1.762) 1.05 (0.52-1.514) 
BA Diameter (mm) 0.5698 (0.437-0.738) 0.7868 (0.503-0.991) 0.665 (0.507-0.923) 
Stroke Volume (mm3) 0.3706 (0.06-0.679) 0.5145 (0.225-0.812) 0.4444 (0.169-0.698) 
Ejection Fraction 46.81 (36.14-59.82) 46.09 (38.29-58.17) 41.69 (32.51-51.28) 
Fractional Shortening 19.8 (7.273-33.69) 22.16 (10.28-30.53) 17.3 (9.664-31.22) 
Tei Index 0.5892 (0.4194-0.7297) 0.575 (0.3692-0.9811) 0.5414 (0.2353-1.155) 
Cardiac Output (mm3/min) 25.38 (5.34-52.65) 34.32 (18.45-69.83) 33.85 (14.2-66.31) 
 
Table 2-1. Means and ranges for echocardiographic measurements of early-life adult 
(ELA) zebrafish. The means and ranges for all echocardiographic measurements of ELA 
fish at the three time points (1, 2, and 3) which correspond to three months, four months, 




Parameters and Measurements Mean (range) MLA 1  
Mean (range) 
MLA 2  
Mean (range) 
MLA 3 
AV Measurements    
Early (E) Diastolic Filling (mm/s) 15.67 (8.202-32.81) 18.95 (8.919-30.08) 18.7 (10.94-30.08) 
Late (A) Diastolic Filling (mm/s) 103.5 (46.48-227) 113.6 (54.69-169.6) 113.1 (51.96-158.1) 
E/A 0.1865 (0.06378-0.4444) 0.2078 (0.07408-0.4231) 0.1869 (0.09434-0.4211) 
Velocity Time Integral (mm) 7.374 (2.263-10.75) 7.458 (4.751-11.13) 7.877 (3.507-13.26) 
IVCT (ms) 35.62 (15-45) 35 (30-45) 33.75 (20-65) 
IVRT (ms) 62.91 (51.6-81.7) 68.75 (41.6-103) 69.79 (9-121) 
    
BV Measurements    
Heart Rate (bpm) 74.2 (56-104) 88.4 (51-127) 80.25 (63-100) 
BV Mean Velocity (mm/s) 49.76 (26.56-78.07) 46.51 (25.19-78.87) 57.4 (32.24-95.42) 
BV Peak Velocity (mm/s) 84.92 (43.75-141.3) 78.65 (38.91-137.1) 100.7 (54.12-172) 
Velocity Time Integral (mm) 9.954 (4.382-18.44) 8.466 (4.545-14.66) 11.45 (6.747-22.24) 
Ventricular Ejection Time (ms) 152 (120-190) 149 (120-180) 161.9 (140-185) 
    
Ventricular and BA Measurements    
Systolic Area (mm2) 0.8763 (0.554-1.458) 0.9234 (0.452-1.608) 0.9005 (0.562-1.41) 
Diastolic Area (mm2) 1.322 (1.041-2.039) 1.405 (0.724-2.202) 1.395 (0.832-2.106) 
Systolic Volume (mm3) 0.6051 (0.323-1.234) 0.6315 (0.199-1.401) 0.6281 (0.313-1.112) 
Diastolic Volume (mm3) 1.084 (0.768-2.035) 1.198 (0.433-2.331) 1.178 (0.541-2.031) 
BA Diameter (mm) 0.6968 (0.335-0.949) 0.6847 (0.488-0.955) 0.8146 (0.62-0.988) 
Stroke Volume (mm3) 0.4844 (0.296-0.801) 0.566 (0.234-0.929) 0.5501 (0.229-0.919) 
Ejection Fraction 44.7 (37.28-57.95) 48.49 (39.88-55.84) 46.16 (40.53-56.74) 
Fractional Shortening 21.4 (6.292-32.38) 17.82 (9.649-26.28) 20.77 (11.12-30.84) 
Tei Index 0.6412 (0.5089-0.8174) 0.6954 (0.5628-0.8331) 0.6313 (0.1871-0.8432) 
Cardiac Output (mm3/min) 35.55 (16.58-47.37) 49.31 (21.11-69.78) 43.69 (15.57-67.78) 
 
Table 2-2. Means and ranges for echocardiographic measurements of mid-life adult 
(MLA) zebrafish. The means and ranges for all echocardiographic measurements of ELA 
fish at the three time points (1, 2, and 3) which correspond to nine months, ten months, 



















Figure 2-1. Acquiring echocardiography measurements for adult zebrafish. (a) The adult 
zebrafish is placed dorsal-side down (ventral side up) in a custom-made clay mold (fit to 
the size of the fish), inside a larger trough with water and anesthetic. Gel is placed on the 
VisualSonics 70MHz ultrasound transducer probe and is lowered onto the fish so an 
interface is established between the water and the gel. It is imperative the probe is 
directly parallel the fish. (b) During B-mode lateral imaging, the atrium (red), ventricle 
(purple), and the bulbus arteriosus (blue) are clearly visible. (c) To calculate anatomical 
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measurements for the ventricle, the epicardium is traced using the Visual Sonics program 
while in diastole (red) and labeled Ld. (d) Next, the ventricle in systole is measured 
(green). This can be marked Ls. The diameter of the bulbus arteriosus can also be 
measured. Measurements calculated from both traces include: area (systole and diastole), 
volume (systole and diastole), EF, and FS. (e) Color Doppler is used to image blood flow 
directionality. In this color Doppler echocardiogram, blood is flowing away from the 
atrium into the ventricle (inflow, red). (f) The blue flow represents outflow from the 
ventricle into the bulbus arteriosus. (g) During lateral imaging of the adult zebrafish, PW 
Doppler is used to capture blood flow through the AV valve. Measurements determined 
include: early (E) diastoltic flow and late diastolic atrial (A) velocities, velocity time 
integral (VTI), ventricular ejection time (VET), isovolumetric contraction time (IVCT), 
and isovolumetric relaxation time (IVRT). (h) PW Doppler is also used to capture blood 





Figure 2-2. Size of adult zebrafish by age. Age (3 months, 4 months and 5 months) is on 
the x-axis. Body weight is in grams is on the y-axis. The size of the fish varies 



















Figure 2-3. Sizes of zebrafish differ between female and male fish. Female fish are 
statistically significantly larger compared to male fish as determined by weight (P = 





Figure 2-4: Correlation plot between traits, measurements, and parameters determined by 
echocardiography. Measurements and parameters captured by ECG were plotted by 
correlation analysis. A blue circle shows a direct correlation whereas a red circle shows 
an anti-correlation. The size and shade of color shows the strength of correlation (direct 





Figure 2-5. Systolic diameter of the bulbus arteriosus (BA) needs to be adjusted for body 
weight. The top plot shows raw diameter measurements of the bulbus arteriosus (y-axis) 
as a function of body weight (x-axis) of the same fish for wild-type fish. Regression 
analysis determines R2 = 0.32. The bottom plot shows residuals for the diameter of the 
bulbus arteriosus in systole (y-axis) regressed against body weight of the same fish (x-






Figure 2-6. Correlation plot between residuals of measurements and parameters 
determined by echocardiography. The same correlation analysis was performed as in 
Figure 2-4, but residuals of the measurements and parameters were plotted rather than 
raw measurements. A blue circle shows a direct correlation whereas a red circle shows an 
anti-correlation. The size and shade of color shows the strength of correlation (direct or 





Figure 2-7. Correlation plot between residuals of measurements and parameters 
determined by echocardiography for female fish only. Residuals of the measurements and 
parameters for female wild-type fish were plotted by correlation analysis. A blue circle 
shows a direct correlation whereas a red circle shows an anti-correlation. The size and 
shade of color shows the strength of correlation (direct or anti-) where 1 and -1 are the 





Figure 2-8. Correlation plot between residuals of measurements and parameters 
determined by echocardiography for male fish only. Residuals of the measurements and 
parameters for male wild-type fish were plotted by correlation analysis. A blue circle 
shows a direct correlation whereas a red circle shows an anti-correlation. The size and 
shade of color shows the strength of correlation (direct or anti-) where 1 and -1 are the 
strongest direct and anti- correlation, respectively.  
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Chapter 3: Development of electrocardiography for adult zebrafish 
 
3.1 Introduction 
 Electrocardiographic (ECG) measurements of adult zebrafish performed 
previously demonstrate clear P waves, QRS complexes and T waves as seen in human 
ECG traces (Milan et al., 2006). Although these studies helped define ECG 
measurements in zebrafish, most analyses were terminal. They required perfusion and the 
invasive placement of a needle electrode in the heart tissue. Further, it has not been used 
in longitudinal analyses and a limited number of groups have performed it in tandem with 
echocardiography (Y. Sun et al., 2015). Here we set out to complete a comprehensive 
pipeline, facilitating genesis of longitudinal echocardiographic and ECG data, collected 
in parallel. This chapter establishes the ECG standard operating procedure, collecting 
ECG measurements on two sets of wild-type fish in a longitudinal study (early-life adults 
and mid-life adult fish), and finally, determines covariates and random effects that must 
be taken into account for future ECG studies, similar to the echocardiography data (See 




3.2.1 Establishing a protocol for ECG 
 Using the iWorx Zebrafish ECG Recording and Analysis System, we are able to 
capture high-quality ECG traces with unprecedented simultaneous analysis of all traits 
typically examined in a clinical setting including, but not limited to HR, PR interval, 
QRS complex, and QT interval. The fish are anesthetized using a solution of 2-
phenoxyethanol, almost completely extinguishing gill movement, which can affect traces 
captured by the machine. Once appropriately anesthetized, the zebrafish are removed 
from anesthesia and placed dorsal side down on the apparatus (Figure 3-1a). Gel is then 
placed on the Ag/Ag-Cl electrodes, which are lowered until they make light contact with 
the surface of the ventrum. The electrodes are positioned such that the most cranial 
electrode sits immediately at the edge of the gills, along the midline of the fish (Figure 3-
1a). It is imperative that the electrodes sit on the skin versus the fins. Once the fish is 
properly positioned, the ECG trace of the fish\ is recorded for five minutes using the 
iWorx Zebrafish ECG Recording and Analysis System software. In our analysis pipeline, 
we first select an interval of the captured ECG trace as being representative of the overall 
wave pattern (Figure 3-1b). This time window typically contains one QRS complexes 
(n~1) and must begin prior to the initiation of a new electrical waveform i.e. including a 
P wave and end after a completed T wave. Once the representative trace is selected, it is 
applied to define waveforms throughout the entirety of the data recording for that 
individual fish. Traces are plotted to include the R amplitude of each interval. In this way, 
outliers can be readily identified and removed (Figure 3-1c). Finally, the average 
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waveform trace for each fish is labeled manually to denote the P, Q, R, S, and T waves 
for each electrophysiological wave (Figure 3-1d). 
 
3.2.2 Determining biological covariates for electrocardiography data 
 Unlike the echocardiography study, few groups have performed ECG analysis on 
zebrafish and no group has published ECG data using this surface ECG machine. We 
therefore set out to establish wild-type ECG measurements and determine any covariates 
in age, sex, body size/volume/mass parameters that must be adjusted for, similar to the 
echocardiography data. To establish a more complete picture of zebrafish heart metrics 
over time, we acquired ECG data corresponding to each time point for the early-life adult 
(ELA) and mid-life adult (MLA) cohorts (the same fish used in the echocardiography 
study, see Chapter 2). For the ELA cohort, measurements were taken once a month at 
three months, four months, and five months of age and as close to the date of 
echocardiography as possible. Similarly, for the MLA cohort, we took measurements at 
nine, ten, and 11 months of age and performed ECG as close to the date of 
echocardiography as well. This was done to get a complete analysis and complete 
phenotype for each fish heart at a single point in time – both anatomical and 
physiological. For each set of measurements, individual fish underwent ECG analysis for 
five minutes (to capture the ECG recording) and were returned to a tank for recovery. 
Fish were maintained in individual tanks to avoid the risk of “sample switching” and to 
control for food intake. Food intake can greatly affect the size of the individual fish and 
by keeping the fish by itself the competition for food is removed. Once these data on the 
two groups of fish were collected, we then evaluated how best to analyze these ECG data 
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with respect to the working hypothesis that the size of the fish could affect the capturing 
the most accurate ECG or the electrophysiology of the fish and then must be adjusted for 
in analysis of the electrophysiology.  
 
3.2.3 Body size affects ECG measurements 
 We then performed a correlation analysis against all ECG measurements and 
body size parameters of the fish including body weight, length, and width. The 
correlation plot describes the relationship between anthropometric parameters and all 
measured ECG traits. To generate this plot and analysis, each parameter and ECG 
measurement was plotted against all other traits and itself (Figure 3-2). For each trait-trait 
pair, a correlation relationship was determined and shown visually by a colored dot 
(either blue or red for direct or anti-correlation, respectively). The stronger the 
correlation, the dot for each trait-trait pair is darker in color and the larger in size. As seen 
in Figure 3-2, sex was not included in the analysis since our previous analysis showed 
that sex affects size (Figure 2-2). As seen in Figure 3-2, the correlation plot revealed that 
body length, width and body weight are each correlated with a majority of measurements. 
Length and weight are more correlated, directly or inversely, with the ECG 
measurements than body width. Heart rate and QT interval are most correlated with the 
body size parameters. PR interval is slightly less correlated and QRS is least correlated 
with body size parameters. This correlation plot shows, for ECG, like echocardiography, 
body size parameters are critical for evaluation. 
 
3.2.4 Adjustment for body size removes correlation between measurements 
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 These correlations derived from analysis of raw measurements are seen in Figure 
3-2. The correlations need to be removed and body size parameters need to be adjusted 
for. We re-determined the correlations between all echocardiographic traits and 
measurements, adjusting for body size parameters, by performing correlation analysis on 
the residuals of the measurements rather than the raw measurements themselves (Figure 
3-3). Correlations seen previously without adjustment are now corrected. The circles that 
mark correlations between, for example, QT interval or heart rate and the body size 
parameters are now gone. The adjustment for body size parameters now allows us to see 
any true correlations in the data, such as in the echocardiography data set. As seen in 
Figure 3-3, few correlations between the ECG measurements remain after the adjustment. 
These correlations are between heart rate and PR interval and QRS interval with QT 
interval. Interestingly, our data does not show a correlation between QT interval and 
heart rate. This is not expected since in humans, QT interval and heart rate are correlated 




 After investigation into echocardiography analysis, we proceeded to perform the 
same correlation analyses on electrocardiography data to determine factors that needed to 
be adjusted to establish the most accurate way to model the data. We determined this 
model would be a linear mixed effects model to adjust for the traits and parameters 
shown to correlate with ECG measurements, including body weight, body length, and 
body width. Since these body size parameters were shown earlier (Figure 2-2 and Figure 
2-3) to be affected by age and sex of the fish, these were also included as covariates. 
Again, as with the echocardiography model, each covariate was added systematically into 
the final model and each model was compared using ANOVA, confirming the covariate 
changed the model in statistically significant manner. The final covariates for the ECG 
model were group (which will be genotype in future studies), type (mutant line or AB 
lines for future studies), age, sex, and body size parameters (body weight, body length, 
and body width). These covariates are all fixed effects. The final covariate is date of 
ECG, as a random effect. Due to the nature of the protocol for ECG, each fish is placed 
under the electrodes individually. We try to keep this as standardized as possible, but 
unfortunately, day of ECG does have an effect. These small changes can affect the 
readings and cause batch effects. To control for this, date of ECG was included as a 
random effect. The protocol for reading the ECG measurements (taking the 
measurements) is not set-up dependent and typically all ECG measurements are read for 
a single study in one day, and therefore was not included in the final model. The final 
model for all future analysis is: lmer(trait) ~ group + type + body weight + body length + 




3.4.1 Zebrafish maintenance. All adult (three months and older) wild type (AB) 
zebrafish lines were maintained in system water according to standard methods 
(Westerfield, 2007). Animal upkeep and experimental procedures were in accordance 
with the ethical permits set by the Johns Hopkins Institutional Animal Care and Use 
Committee. 
 
3.4.2 Electrocardiography. ELA and MLA zebrafish cohorts were evaluated by ECG 
using the iWorx Zebrafish ECG Recording and Analysis System. To facilitate recording, 
all zebrafish were individually anesthetized using a solution of 2-phenoxyethanol (Fluka 
Analytical 77699-250ML) diluted 1:1000 in aquarium water. Each fish is placed into the 
solution for two to three minutes (or until there is minimal gill) movement. Body weight 
and length measurements for each fish were recorded prior to ECG. The fish is placed 
dorsal side down (ventral side up) on the provided pedestal and the electrodes are 
positioned such that the most anterior electrode is sits immediately at the caudal edge of 
the gills, along the midline of the fish (Figure 2a). Data is recorded for five minutes using 
the iWorx Zebrafish ECG Recording and Analysis System software before the fish is put 
into a recovery tank full of clean system water. The Labscribe3 software (iWorx) was 
used to analyze ECG data and calculate measures of cardiac electrophysiology. To limit 
the potential for noise introduced into the recordings by electrostatic or electromagnetic 




3.4.3 Statistical Analysis. Correlation plots were generated using the corrplot() package 
in R version 3.2.3. A linear mixed model estimated the effect of group on mutation status. 
Age, sex, body size parameters, and type were included as covariates with date of 
echocardiography as a random effect: lmer(trait) ~ group + type + body weight + body 
length + body width + age + sex + (1 | date of ECG) All statistical analyses were 





























Figure 3-1. Acquiring electrocardiography measurements for adult zebrafish. (a) To 
capture electrocardiography measurements, the adult zebrafish is placed dorsal side down 
on the pedestal. (b) Using the iWorx Zebrafish ECG Recording and Analysis System, 
first, a single complex of the captured ECG trace is chosen to determine the overall wave 
pattern for the larger, five minute trace. Individual rhythm strips for each fish are 
identified for artifacts and outliers. (c) Any additional outlier strips not captured by the 
software are manually removed (black outlined trace is identified as an outlier in 
comparison to the gray traces). (d) The average rhythm strip for each fish (red) is 

















Figure 3-2. Correlation plot between traits, measurements, and parameters determined by 
electrocardiography. Measurements and parameters captured by ECG were plotted by 
correlation analysis. A blue circle shows a direct correlation whereas a red circle shows 
an anti-correlation. The size and shade of color shows the strength of correlation (direct 
or anti-) where 1 and -1 are the strongest direct and anti- correlation, respectively. 
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Figure 3-3. Correlation plot between residuals of measurements and parameters 
determined by electrocardiography. The same correlation analysis was performed as in 
Figure 3-2, but residuals of the measurements and parameters were plotted rather than 
raw measurements. A blue circle shows a direct correlation whereas a red circle shows an 
anti-correlation. The size and shade of color shows the strength of correlation (direct or 
























































































































































































































































































Chapter 4: Validation of echocardiography and electrocardiography 
 
4.1 Introduction 
 After establishing baseline measurements via echocardiography and 
electrocardiography for wild-type fish of ages commonly used in laboratory settings, we 
applied these methods to two well-characterized mutant lines. First, the mutant line of the 
gene, kcnh6a, kcnh6atb218 has been previously described with an embryonic phenotype of 
2:1 AV block. This means there is a defect in the electrical signal reaching the 
atrioventricular node and results in the atrium contracting twice for a single ventricular 
contraction (Kopp et al., 2005; Meder et al., 2011). On an ECG trace, this is picked up as 
two individual P waves for every one QRS complex. This phenotype is only seen in 
embryos. Adult kcnh6atb218 mutants were found to have elongated QT intervals, or 
defects in the repolarization of the ventricle (Meder et al., 2011). Although these data was 
recorded with a surface ECG machine, it was custom-made and very low resolution 
(Hassel et al., 2008). Another allele of kcnh6a, the kcnh6as290 mutant line has also been 
used as a model for arrhythmia and QT duration perturbation. Using electrocardiography 
in adult heterozgyote mutant fish and wild-type fish, a previous group found heterozygote 
kcnh6as290 fish had a prolonged QTc interval, suggesting delayed ventricular 
repolarization (R Arnaout et al., 2007). This group used an established 
electrocardiography protocol by Milan et al., where anesthetized fish were perfused and 
two needle electrodes were inserted into each fish and ECG measurements were captured 
for hours at a time (Milan et al., 2006). For both of these studies in adult fish, physical 
parameters including sex and body size were not adjusted for in analysis. Furthermore, no 
 
 53 
echocardiography has ever been performed on either line. We decided to test our methods 





4.2.1 kcnh6atb218 mutants do not show electrophysiological dysfunction 
 To further demonstrate our newly optimized methods and our analysis, we first 
studied kcnh6atb218 mutant fish. Embryos in our hands show a definitive 2:1 AV block, as 
described in the literature (two atrial beats to one ventricular beat) (data not shown). We 
then proceeded to analyze adult mutants with the ECG machine and application of our 
linear mixed effects model. Analysis via ECG demonstrated no significant differences 
between homozygous kcnh6atb218 fish and wild-type controls (Table 4-1). A longer PR 
interval is representative of 2:1 AV block, clinically. PR interval was not significantly 
different between kcnh6atb218 fish and wild-type controls. Anticipating that detection of 
PR interval extension may be obstructed by e.g. a bifurcated P wave, each trace was 
again examined by eye, but no qualitative differences in traces were seen. Previous 
studies showed an elongated QT interval, but that too was not seen either by our rigorous 
methods. 
 
4.2.2 kcnh6atb218 mutants do not show anatomical dysfunction 
 Next, kcnh6atb218 fish and wild-type controls were analyzed via echocardiography 
for structural defects as well as blood flow velocity abnormalities. Echocardiographic 
analysis has not been published for kcnh6atb218 fish. In the analysis of measurements, we 
adjusted for age, sex, and body size parameters with date of echocardiography as a 
random effect. We report no significant and meaningful differences between any of the 
traits examined, including anatomical differences, flow differences through the AV valve, 
or BV valve (Table 4-2). Although ECG data and echocardiographic data should be 
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examined separately, the lack of any differences in the structure of the fish heart or blood 
flow pattern is consistent with the ECG analysis of the kcnh6atb218 mutants. 
 
4.2.3 kcnh6as290 mutants show elongated QRS and QT intervals by ECG 
 Next, we examined another mutant line of the gene, kcnh6a. We hypothesized a 
long QT interval in both mutant embryos and adults. However, no overt or gross 
electrophysiological difference was visualized in mutant embryos (data not shown). 
Analysis of kcnh6as290 by ECG as described in Chapter 3 showed an interesting 
difference in kcnh6as290 traces compared to traces from wild-type controls. Interestingly, 
there were significant differences between traits QRS complex and QT interval (Table 4-
3). For both traits, the kcnh6as290 mutants have significantly faster QRS intervals (***P < 
0.001) and QT intervals (**P < 0.01, Table 4-3). This suggests dysfunction of ventricular 
repolarization. This is consistent what has been previously described in the literature. 
 
4.2.4 kcnh6as290 mutants show an increased velocity time integral through the AV valve 
by echocardiography 
 To further characterize the kcnh6as290 arrhythmia and long QT model, we 
performed full analysis via echocardiography. We examined all measurements related to 
ventricular size in systole and diastole, BA diameter, and blood flow through both the BV 
and AV valves and applied the linear mixed effects model. This analysis revealed only 
one significant difference between mutant and wild-type fish – velocity time integral 
(VTI) through the AV valve. The time integral was significantly decreased (in 
millimeters) in the mutant fish than the wild-type fish. This suggests there are no 
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structural phenotypes in kcnh6as290 fish, solely an electrophysiological one that may 
affect blood flow through the AV valve (*P < 0.05, Table 4-2). Blood flow through the 
AV valve is determined in the Visual Sonics echocardiography analysis program, by 
placing a gate across the AV valve. From this, we calculate late diastolic filling (A peak), 
early diastolic filling (E peak), IVCT, IVRT, and the velocity time integral. No other 
traits involving blood flow through the AV valve were different between the two groups 




 To apply the methods as well as the model of analysis that I developed in 
Chapters 2 and 3, we used two mutant lines of the same gene, kcnh6a. These two lines 
each have a specific and unique point mutation generated via ENU mutagenesis. These 
lines have both been carefully analyzed and phenotyped previously by other groups in the 
field that report 2:1 AV block in embryos and an elongated QT interval in adults. In our 
hands with our ECG machine and our model of analysis, we did not determine any 
cardiac conductance differences between kcnh6atb218 mutants and wild-type fish. We also 
performed echocardiography on these fish and saw no structural defects either. It should 
be noted that we do see the embryonic cardiac phenotype that was reported by Meder et 
al. Biologically, little is known regarding heart development in zebrafish between 
embryonic and adulthood. This line could be used in the future to determine the changes 
in electrophysiology from early development into adulthood and what could cause a loss 
of arrhythmia. Potentially, these mutant fish and these adulthood data could be very 
useful in studying sudden cardiac death, where lethal arrhythmia hits in adulthood. This 
change in electrophysiology in zebrafish is ripe for discovery. 
 The second mutant line has also been studied as embryos and adults. This point 
mutation at homozygosity is lethal and the adult heterozygous fish have been reported to 
have prolonged QT intervals. In our hands and with our machine and our model of 
analysis, we see that the kcnh6as290 fish do have a significantly prolonged QRS complex 
and QT interval. This confirms the literature and also illustrates that our methods are 
working. These fish were also analyzed by echocardiography and were found to have a 
lower velocity time integral. Since flow velocity varies during the ejection of blood in the 
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heart, the velocity time integral is used to determine the sum of the flow velocity. 
Decreased velocity time integral may be suggestive of the effects of the arrhythmia on the 
ventricle. To conclude, these two well-characterized mutant lines were studied further 
and these data adds to that characterization. These lines, especially the kcnh6as290 line, 
prove that with the ECG machine and our analysis, we are able to pick up arrhythmias 





4.4.1 Zebrafish maintenance. All adult (three months and older) wild type (AB) 
zebrafish lines were maintained in system water according to standard methods 
(Westerfield, 2007). Animal upkeep and experimental procedures were in accordance 
with the ethical permits set by the Johns Hopkins Institutional Animal Care and Use 
Committee. 
 
4.4.2 Electrocardiography. Zebrafish cohorts were evaluated by ECG using the iWorx 
Zebrafish ECG Recording and Analysis System. To facilitate recording, all zebrafish 
were individually anesthetized using a solution of 2-phenoxyethanol (Fluka Analytical 
77699-250ML) diluted 1:1000 in aquarium water. Each fish is placed into the solution for 
two to three minutes (or until there is minimal gill) movement. Body weight and length 
measurements for each fish were recorded prior to ECG. The fish is placed dorsal side 
down (ventral side up) on the provided pedestal and the electrodes are positioned such 
that the most anterior electrode is sits immediately at the caudal edge of the gills, along 
the midline of the fish (Figure 2a). Data is recorded for five minutes using the iWorx 
Zebrafish ECG Recording and Analysis System software before the fish is put into a 
recovery tank full of clean system water. The Labscribe3 software (iWorx) was used to 
analyze ECG data and calculate measures of cardiac electrophysiology. To limit the 
potential for noise introduced into the recordings by electrostatic or electromagnetic 




4.4.3 Echocardiography. To capture high-resolution images, the Vevo 2100 Imaging 
System equipped with a 70 MHz ultrasound transducer was used (VisualSonics®, 
Toronto, ON, Canada). The following settings were used for all reported zebrafish 
echocardiography sessions: imaging frequency, 50 MHz for B-Mode, 40 MHz for 
Pulsed-Wave (PW) Doppler and color Doppler, 10-20 Hz pulse repetition frequency, 
adjusted as necessary, 30-35 Db Doppler gain, 200 frames per second in B-mode, and 7 
mm image depth. The zebrafish (n=10 per group) were anesthetized by placing the fish 
into a plastic cup filled with 100 ml of 168 µg/ml MS-222 (tricaine methane sulfonate). 
Stage 3 anesthesia (loss of equilibrium, decreased opercular movement rate, no voluntary 
locomotion, non-responsive to stimuli) was obtained prior to imaging and maintained 
throughout the period of data recording. Fish were weighed and measured for width and 
length and then stabilized in the clay mold within the plastic trough filled with MS-222, 
leaving only the most ventral surface of the ventrum exposed. A thin layer of Parker 
Aquatic 100 ultrasound gel was then applied to the transducer array (2-3 mm) using a 
cotton swab. n.b. Excessive amounts of ultrasound gel may result in suffocation of the 
fish.  
 The transducer probe was positioned in a vertically within the manipulator with 
the notch facing caudally, meaning the transducer surface lies longitudinally over the 
ventrum of the fish along the anterior-posterior axis. Thus, the ultrasound beam is thus 
perpendicular to the long axis of the fish. The transducer was lowered towards the fish 
until it makes contact with the gel and the heart is visualized in B-Mode. Touching the 
transducer to the surface of the fish will distort the signal. Two-dimensional B-Mode 
imaging was used to obtain videos of the heart, including ventricle, atrium, and bulbus 
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arteriosus, in long axis view. These 100 frame cine loops were then analyzed using the 
Vevo Lab Software cardiac package. 
 The left ventricular trace function was used to trace the epicardial surface of the 
ventricle in systole and diastole, calculating ventricular systolic and diastolic areas and 
volumes, stroke volume (SV), ejection fraction (EF), and fractional shortening (FS). The 
diameter of the bulbus arteriosus was measured using the aortic arch function while in 
ventricular systole. Color Doppler mode was used to determine location, direction, and 
velocity of blood flow through the heart. While in long axis view and color Doppler 
mode, PW Doppler mode was used to display the sample volume overlay on the color 
Doppler mode image. The sample volume wireframe was moved in order to acquire 
velocity measurements from the ventricular outflow tract (VOT), which should appear 
blue in color Doppler mode. The Doppler angle was adjusted to align the yellow gate as 
parallel as possible to blood flow through the VOT. Cine loops were captured as desired 
and analyzed to calculate the heart rate (HR), mean and peak outflow velocities through 
the VOT, velocity time integral (VTI), and ventricular ejection time (VET). Next, the 
wireframe was moved to acquire velocity measurements through the atrioventricular 
(AV) valve, which should appear red in color Doppler mode. Cine loops were captured 
and used to calculate early (E) and late (A) diastolic filling velocities, AV VTI, 
isovolumetric contraction time (IVCT), and isovolumetric relaxation time (IVRT). The 
Doppler angle was adjusted to align the yellow gate as parallel as possible to the flow of 
blood through the AV valve and cine loops were captured. The Tei index, also known as 
the myocardial performance index, was calculated from (IVCT+IVRT)/(VET). The 
cardiac output was calculated from SV multiplied by HR. The fish were removed from 
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the imaging trough and placed in a cup of fresh room temperature aquarium water to 
facilitate recovery from anesthesia. To ensure optimal recovery, imaging sessions lasted 
no longer than 10 minutes. Evaluated zebrafish were then returned to individual tanks to 
recover. 
 
4.4.4 Statistical Analysis. A linear mixed model estimated the effect of group on 
mutation status. Age, sex, body size parameters, and type were included as covariates 
with date of echocardiography as a random effect: lmer(trait) ~ group + type + body 
weight + body length + body width + age + sex + (1 | date of echocardiography/ECG) All 





Measurements Mean (range) for wild-type  Mean (range) for kcnh6atb218  P-value 
Heart rate 58.97 (36, 74.12) 59.8 (14, 178) 0.46 
PR Interval 62.26 (49.95, 85.12) 57.58 (22.55, 67.13) 0.73 
QRS Interval 30.31 (21.03, 44.8) 36.2 (22.55, 67.13) 0.94 
QT Interval 227.9 (127.1, 309.5) 206.3 (89.6, 458.7) 0.10 
 
Table 4-1. There are no electrophysiological differences between wild-type and 
kcnh6atb218 mutant adult fish. For each trait, the mean and range values in milliseconds 
are listed for wild-type fish and kcnh6atb218 mutant fish. Each P-value was determined 
using a linear model where each group was analyzed and type, body weight, body length, 
body width were all adjusted for as covariates and date of ECG was included as a random 
effect: lmer(trait) ~ group + type + body weight + body length + body width  + sex + (1 | 
date of ECG). n =  49; 44 kcnh6atb218 mutants, 5 wild-type fish. A P-value < 0.05 was 





Parameters and Measurements Mean (range) wild-type  Mean (range) kcnh6atb218 P-value 
AV Measurements    
Early (E) Diastolic Filling (mm/s) 20.69 (11.28-30.08) 21.55 (-33.84-40.01) 0.502 
Late (A) Diastolic Filling (mm/s) 85.04 (63.92-116.6) 116.8 (41.36-186.8) 0.922 
E/A 0.2525 (0.15-0.4118) 0.2201 (-0.2368-0.4545) 0.663 
Velocity Time Integral (mm) 6.691 (5.076-9.343) 8.733 (4.775-12.28) 0.681 
IVCT (ms) 37.67 (23.33-55) 38.57 (20-50) 0.973 
IVRT (ms) 52.67 (23.33-100) 65.24 (30-105) 0.665 
    
BV Measurements    
Heart Rate (bpm) 107.2 (89.22-128.3) 100.8 (81.19-115.9) 0.51 
BV Mean Velocity (mm/s) -43.74 (-65.66--23.84) -48.44 (-78.48--20.91) 0.828 
BV Peak Velocity (mm/s) -67.39 (-105.3--34.36) -78.42 (-124.5--32.01) 0.826 
Velocity Time Integral (mm) 8.294 (4.773-11.82) 10.44 (4.147-17.71) 0.741 
Ventricular Ejection Time (ms) 157.8 (145-175) 180.7 (150-255) 0.368 
    
Ventricular and BA Measurements    
Systolic Area (mm2) 0.2803 (0.1862-0.4557) 0.3428 (0.1896-0.7017) 0.397 
Diastolic Area (mm2) 0.4286 (0.2765-0.7521) 0.5434 (0.3001-1.094) 0.517 
Systolic Volume (mm3) 0.1091 (0.05622-0.2236) 0.1525 (0.05478-0.4315) 0.421 
Diastolic Volume (mm3) 0.2072 (0.1085-0.4824) 0.2918 (0.1157-0.9241) 0.427 
BA Diameter (mm) 0.4966 (0.3902-0.6666) 0.4974 (0.2774-0.7889) 0.639 
Stroke Volume (mm3) 0.09811 (0.03831-0.2588) 0.1393 (0.04042-0.4926) 0.393 
Ejection Fraction 47.52 (15.35-60.41) 47.76 (19.15-66.61) 0.884 
Fractional Shortening 16.31 (-0.9625-30.97) 21.8 (7.068-42.81) 0.857 
Tei Index 0.5729 (0.4-0.871) 0.61 (0.28-1.033) 0.826 
Cardiac Output (mm3/min) 10.86 (4.257-33.22) 13.64 (4.151-39.99) 0.363 
 
Table. 4-2. There are no anatomical differences between wild-type and kcnh6atb218 
mutant adult fish as determined by echocardiography. For each trait, the mean and range 
values in the respective units are listed for wild-type fish and kcnh6atb218 mutant fish. 
Each P-value was determined using a linear model where each group was analyzed and 
type, body weight, body length, body width were all adjusted for as covariates and date of 
echocardiography was included as a random effect: lmer(trait) ~ group + type + body 
weight + body length + body width  + sex + (1 | date of echocardiography), n =  49; 44 
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Measurements Mean (range) for wild-type  Mean (range) for kcnh6as290  P-value 
Heart rate 43.82 (21, 78) 61.13 (18, 178) 0.12 
PR Interval 57.92 (14.6, 71.68) 71.24 (47.13, 109.76) 0.08 
QRS Interval 31.14 (14.54, 53.2) 47.14 (19.04, 78.10) 0.00018 
QT Interval 192.4 (109.6, 283.3) 263 (164.6, 401.5) 0.0025 
 
 
Table. 4-3. kcnh6as290 adult zebrafish have longer QRS and QT intervals compared to 
wild-type fish. For each trait, the mean and range values in milliseconds are listed for 
wild-type fish and kcnh6as290 mutant fish. Each P-value was determined using a linear 
model where each group was analyzed and type, body weight, body length, body width 
were all adjusted for as covariates and date of ECG was included as a random effect: 
lmer(trait) ~ group + type + body weight + body length + body width  + sex + (1 | date of 
ECG), n =  51; 33 kcnh6as290 mutants, 18 AB fish. A P-value < 0.05 was considered 







Parameters and Measurements Mean (range) wild-type  Mean (range) kcnh6as290 P-value 
AV Measurements    
Early (E) Diastolic Filling (mm/s) 13.95 (7.52-26.32) 10.31 (7.52-15.57) 0.533 
Late (A) Diastolic Filling (mm/s) 116.8 (60.16-175.5) 132.1 (67.68-240.6) 0.427 
E/A 0.1254 (0.04545-0.2105) 0.0898 (0.03125-0.2222) 0.906 
Velocity Time Integral (mm) 9.017 (3.471-18.37) 8.312 (3.741-13.25) 0.0267 
IVCT (ms) 28.8 (20-40) 27.78 (15-36.67) 0.281 
IVRT (ms) 71.76 (40-125) 48.33 (20-100) 0.139 
    
BV Measurements    
Heart Rate (bpm) 101.3 (60.2-146.5) 102 (63.38-126.5) 0.937 
BV Mean Velocity (mm/s) -60.86 (-97.39--30.61) -62.71 (-100.4--24.94) 0.587 
BV Peak Velocity (mm/s) -96.2 (-157.3--44.17) -99.07 (-170.4--31.9) 0.416 
Velocity Time Integral (mm) 13.6 (5.931-21.24) 14.2 (6.208-21.86) 0.732 
Ventricular Ejection Time (ms) 185.8 (135-225) 195.4 (130-260) 0.223 
    
Ventricular and BA Measurements    
Systolic Area (mm2) 0.3319 (0.1705-0.6561) 0.3454 (0.1522-0.5176) 0.593 
Diastolic Area (mm2) 0.4798 (0.1929-0.9675) 0.5033 (0.2048-0.7764) 0.401 
Systolic Volume (mm3) 0.1411 (0.04682-0.3415) 0.1566 (0.04182-0.2891) 0.792 
Diastolic Volume (mm3) 0.2438 (0.06133-0.6316) 0.2641 (0.06652-0.5324) 0.421 
BA Diameter (mm) 0.504 (0.2486-0.7224) 0.5256 (0.3414-0.7961) 0.889 
Stroke Volume (mm3) 0.1028 (0.01395-0.3272) 0.1075 (0.008745-0.2685) 0.257 
Ejection Fraction 39.77 (10.54-55.66) 39.56 (11.71-65.12) 0.442 
Fractional Shortening 17.38 (-1.631-30.85) 19.44 (4.694-32.98) 0.954 
Tei Index 0.5695 (0.2667-0.8621) 0.3926 (0.2143-0.6944) 0.0555 
Cardiac Output (mm3/min) 10.62 (0.8396-33.81) 10.91 (0.9464-30.27) 0.26 
 
Table 4-4. kcnh6as290 adult zebrafish have longer velocity time integrals through the 
atrioventricular valve (AV VTI) compared to wild-type fish. For each trait, the mean and 
range values in the respective units are listed for wild-type fish and kcnh6as290 mutant 
fish. Each P-value was determined using a linear model where each group was analyzed 
and type, body weight, body length, body width were all adjusted for as covariates and 
date of echocardiography was included as a random effect: lmer(trait) ~ group + type + 
body weight + body length + body width  + sex + (1 | date of echocardiography ), n =  51; 
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Chapter 5: ROBO4 mutations predispose individuals to bicuspid aortic 
valve and thoracic aortic aneurysm 
 
5.1 Introduction 
 Bicuspid aortic valve (BAV) is the most common congenital heart defect, with a 
population incidence of 1-2%(Fedak et al., 2002; Mack & Silberbach, 2000; Ward, 2000) 
and a strong association with ascending aortic aneurysm (AscAA) (Tadros, Klein, & 
Shapira, 2009). BAV/AscAA shows autosomal dominant inheritance with incomplete 
penetrance and male predominance. Fewer than 1% of cases of nonsyndromic BAV with 
and without AscAA can be attributed to mutations in known disease genes (e.g. 
NOTCH1, SMAD6) (Cripe et al., 2004; Garg et al., 2005; McKellar et al., 2007; Tan et 
al., 2012), frustrating the development of robust pathogenic models and therapeutic 
strategies. We report the identification of mutations in ROBO4, encoding a factor known 
to contribute to endothelial performance, that segregate with disease in two families. 
Additional targeted sequencing of ROBO4 identified enrichment for rare variants in 
individual BAV/AscAA probands compared to unrelated controls. Targeted silencing of 
ROBO4 or expression of mutant ROBO4 in endothelial cell lines imposes relevant 
functional deficits, including impaired barrier function, and a synthetic repertoire highly 
suggestive of endothelial-to-mesenchymal transition (EnMT); concordant findings are 
observed in patients and animal models with BAV/AscAA-associated phenotypes that are 
deficient for ROBO4. These data identify a novel etiology for a common human disease 
phenotype and focus attention on endothelial cell biology. 
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 Kindreds segregating BAV/AscAA often exhibit wide variation in cardiovascular 
manifestations between related affected individuals, including complete non-penetrance 
(skewed toward females), isolated BAV, isolated AscAA, and variable location of the site 
of ascending aortic dilatation including isolated aortic root aneurysm (AoRA), or more 
distal ascending aortic aneurysm (DAscAA; collectively AscAA) (Clementi, Notari, 
Borghi, & Tenconi, 1996; Huntington, Hunter, & Chan, 1997; Loscalzo et al., 2007; 
Mckusick, Logue, & Bahnson, 1957). This observation suggests that BAV and AscAA 
are both variably penetrant primary manifestations of the same underlying gene defect(s). 
While enrichment for BAV can be seen in syndromic presentations of thoracic aortic 
aneurysm (e.g. Loeys-Dietz syndrome caused by mutations in genes encoding primary 
effectors of the transforming growth factor-β (TGFβ) signaling pathway), isolated 
DAscAA is exceedingly rare in these conditions suggesting a mechanistic distinction for 
nonsyndromic BAV/AscAA (Isselbacher, 2005; Van Hemelrijk, Renard, & Loeys, 2010; 
Williams et al., 2007). The genetic etiology and molecular pathogenesis of nonsyndromic 
BAV/AscAA remains largely elusive despite intensive effort. Likely obstacles to 
progress include extreme locus heterogeneity and the confounding influence of 
incomplete penetrance, sex bias, and environmental and/or genetic modification of 
disease onset and severity. In this study, we sought to identify genes responsible for 






5.2.1 Enrichment for ROBO4 variants in patients with BAV and AscAA 
 A total of nine patient families, 286 individual probands, and 193 unrelated 
controls without structural heart disease were enrolled in our whole exome sequencing 
(WES) initiative. In one large family (Family 1), eight individuals showed AoRA with or 
without DAscAA; two had associated BAV (Figure 5-1a). 
 Initial sequencing of a panel of genes implicated in familial thoracic aortic 
aneurysm (ACTA2, FBN1, MYH11, MYLK, SMAD3, TGFBR1/2) (Guo et al., 2007; Loeys 
et al., 2006; Pereira et al., 1997; van de Laar et al., 2012; L. Wang et al., 2010; Zhu et al., 
2006) identified no mutations. WES in five of the affected family members identified a 
novel heterozygous mutation at the splice acceptor site of ROBO4 exon 13 
(c.2056+1G>T) (Figure 5-1a and Figure 5-2a). We confirmed that all eight affected 
family members carried the mutation (data not shown). Interestingly, seven of eight 
affected individuals were male including both with BAV. Two clinically unaffected 
female family members were heterozygous for the ROBO4 splice-site mutation. 
Pathology from one family member with BAV revealed calcium deposition and valve 
thickening in association with a pronounced fibroproliferative process (Figure 5-2b). 
Amplification and sequencing of cDNA derived from patient and control fibroblasts 
showed that the splice-site mutation results in the skipping of the 108 base pairs encoding 
exon 13 of ROBO4, resulting in an in-frame transcript encoding a protein isoform 
missing 36 amino acids from the intracellular domain (Figure 5-1b). In a separate family 
(Family 2), WES revealed a heterozygous ROBO4 missense variant (c.190C>T; 
p.Arg64Cys) in a woman with atrial septal defect (ASD) and aortic valve stenosis (AVS) 
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that required surgery and her son with ASD, BAV and significant AVS (Figure 5-1c and 
Figure 5-2c). This variant is exceedingly rare in population databases (ExAC frequency: 
19/98,998), predicted deleterious by Polyphen and SIFT, and predicted to be among the 
1% most deleterious substitutions possible in the human genome by the Combined 
Annotation Dependent Depletion (CADD) algorithm with a score of 21.6. The mutation 
changes an evolutionarily conserved residue in the Ig-like C2-type 1 extracellular domain 
of ROBO4. Of the 286 individual probands, four variants were determined to meet our a 
priori filtering to focus on all variants that are exceedingly rare (MAF<0.01%), or rare 
and predicted highly deleterious (MAF<0.1% and CADD>20) (Figure 5-1d and Table 5-
1). All variants were confirmed by Sanger sequencing (data not shown). 
 We then sequenced an additional 441 probands with BAV/AscAA and 183 
unrelated controls with echocardiogram-confirmed absence of structural cardiovascular 
disease for ROBO4 mutations using the Haloplex target enrichment system. 99.47% of 
base positions exceeded 10x coverage for ROBO4 in 90% of samples. We identified an 
additional seven BAV/AscAA probands harboring heterozygous ROBO4 variants that 
fulfilled filtering criteria, including five missense mutations and one frameshift mutation 
(Figure 5-1d and Table 5-1). The missense mutations observed in the targeted sequencing 
cohort include an additional example of the p.Arg64Cys variant previously observed in 
Family 2 and two independent occurrences of an exceedingly rare (ExAC frequency: 
4/110,004) and predicted highly deleterious (CADD score 21.3) variant (p.Asp622His) in 
two unrelated probands that were recruited at distant sites. In sum, among familial and 
individual probands (WES and targeted sequencing), 13/736 (1.77%) had a ROBO4 
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variant that passed a priori filtering constraints while one rare (absent in ExAC) missense 
mutation was observed among 376 rigorously phenotyped controls (P < 0.05). 
 
5.2.2 Cellular consequences of ROBO4 variants 
 We next sought to elucidate the functional consequence of mutant ROBO4 alleles. 
Histologic and immunofluorescent analyses were performed on resected ascending aortic 
aneurysm tissue from patient 1.II:1 and compared to normal ascending aorta derived from 
an age- and sex-matched control individual. ROBO4 was strongly expressed in 
endothelial cells in control aorta as evidenced by co-localization with platelet endothelial 
cell adhesion molecule 1 (CD31), but was diminished in the endothelium in the 
BAV/AscAA sample (Figure 5-3a, c). Both control and diseased aorta showed expression 
of ROBO4 in the intima in the absence of co-expression of α-smooth muscle actin (α-
SMA), a vascular smooth muscle cell mesenchymal marker (Figure 5-3b). However, the 
aneurysm tissue uniquely showed infiltration of ROBO4+ cells into the aortic media with 
co-staining for α-SMA. Given expression of ROBO4 in the endothelial lining of the 
vasculature (Park et al., 2003) and its described role in establishing endothelial barrier 
function (Cai et al., 2015; Jones et al., 2008), we hypothesized enhanced vascular 
permeability in the ascending aorta of patients with BAV/AscAA. In keeping with this 
hypothesis, immunostaining for albumin was restricted to the endothelial surface in 
control aorta, but substantial penetration into the aortic intima was observed in patient 
tissue (Figure 5-3d). Histologic analyses showed a strong fibroproliferative response in 
the intima and superficial medial layer of patient aorta, as evidenced by increased 
cellularity and the accumulation of collagen upon Masson’s trichrome staining. There 
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was also decreased elastin content and fragmentation and disarray of elastic fibers in the 
superficial media revealed upon Verhoeff-Van Gieson (VVG) staining (Figure 5-3e). 
Taken together, these data suggest that ROBO4 mutations disrupt endothelial cellular 
performance and barrier function and contribute to pathological remodeling of the aortic 
media. 
 
5.2.3 In vitro functional analysis of ROBO4 variants 
 To further address the hypothesis that ROBO4 mutations directly influence 
endothelial cell performance, cultured human aortic endothelial cells (HAECs) were 
treated with short interfering RNA (siRNA) to silence ROBO4 expression or were 
transiently transfected with expression constructs that overexpress wild-type ROBO4, a 
form lacking exon 13, or a form with the p.Arg64Cys missense variant. In addition, 
HAECs with silenced endogenous ROBO4 expression by siRNA targeting sequence in 
exon 13 were transfected with the expression construct lacking exon 13 (termed SS-
Alone) to assess the individual performance of the mutant form of ROBO4 seen in 
Family 1. The expression of wild-type and mutant ROBO4 mRNA was assessed by 
quantitative reverse transcription-PCR (qRT-PCR) (Figure 5-4a). Either ROBO4 
silencing or expression of mutant forms resulted in loss of endothelial barrier function in 
a dextran permeability assay, with significantly worse performance of SS-Alone cells 
compared to cells lacking any ROBO4 expression (Figure 5-4b). These data document 
that ROBO4 is critical for endothelial barrier function, that ROBO4 mutations have 
dominant-negative potential, and that isolated expression of selected mutant forms of 
ROBO4 can perturb cellular function. Potentially, mutant ROBO4 competes with other 
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members of the Roundabout family in the binding of SLIT ligands despite inability to 
propagate signal or (less likely) through neomorphic activity. Loss of barrier function 
associated with down regulation of expression of TJP1 and VE-cadherin mRNA and 
protein is indicative of loss of tight- and adherens-junction integrity, respectively (Figure 
5-4c). Other phenotypes seen upon either ROBO4 silencing or expression of mutant 
forms in HAECs included induction of expression of α-SMA and cellular elongation and 
invasion (Figure 5-5). Together, these results suggest that ROBO4 contributes to 
maintenance of endothelial identity and performance, and to the suppression of the 
transition to a more mesenchymal invasive character and synthetic repertoire. Both 
functions appear compromised upon expression of ROBO4 alleles seen in patients with 
BAV/AscAA. 
 
5.2.4 Animal models have been used previously to study ROBO4 
 Mommersteeg and colleagues described expression of ROBO1, ROBO2, SLIT2 
and SLIT3 in or adjacent to the endocardial cushions and heart valves during mouse 
development(Mommersteeg, Yeh, Parnavelas, & Andrews, 2015). Targeted homozygous 
disruption of both Robo1 and Robo2 or Slit3 resulted in highly penetrant septal defects 
with variably penetrant valve anomalies, including BAV. By report, ROBO4 expression 
was only observed in the coronary circulation and was therefore excluded from the study. 
In developing mice, we observed that ROBO4 was expressed in the endocardial layer of 
the cushions and delamination zones at embryonic day 11.5 (E11.5; Figure 5-6a). By 
E17, ROBO4 was detected in both the endothelial and interstitial cells of the developing 
aortic valve and endothelial cells of the proximal aorta (Figure 5-6a, b). At 5 weeks after 
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birth, ROBO4 was localized to the endothelial layer of the ascending aorta and 
expression was sustained throughout postnatal development (Figure 5-6b). Previous 
studies in zebrafish demonstrated robo4 expression in the developing vasculature 
beginning at the 19-somite stage and continuing in the intersomitic vessels through 29 
hours post-fertilization(Bedell et al., 2005). In normal adult human ascending aorta, 
ROBO4 is expressed in endothelial and intimal cells (Figure 5-3 and Figure 5-6c). 
Together, these results confirm expression of ROBO4 in cells relevant to the 
pathogenesis of BAV/AscAA. 
 
5.2.5 Loss-of-function robo4 zebrafish demonstrate defects in cardiac function 
 Next, functional evaluation of the ROBO4 ortholog was conducted in zebrafish 
(Danio rerio). Using CRISPR/Cas9 engineering technology, we established a mutant 
zebrafish line harboring a seven bp deletion in exon 6 of the endogenous robo4 gene 
(robo4∆7; Figure 5-7a). This mutation establishes a frameshift resulting in the genesis of a 
premature termination codon. We confirmed nonsense mediated mRNA decay of the 
mutant transcript by qRT-PCR, demonstrating a significant reduction in robo4 RNA in 
both robo4∆7 heterozygote and homozygote zebrafish (Figure 5-7b). Gross examination 
of the mutant genotypes did not reveal an overt larval phenotype (Figure 5-8). Further, all 
genotypes were represented in appropriate Mendelian proportion into adulthood in 
crosses between mutant heterozygotes (Table 5-2). The absence of an overt embryonic 
phenotype or lethality prompted analysis in adult robo4 deficient zebrafish by 
echocardiography. Importantly, ≥26% of assayed mutant zebrafish (7/26 robo4∆7/+ and 
4/15 robo4∆7/∆7) displayed an aberrant echocardiogram characterized by regurgitation, 
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blood flow turbulence, or extreme outflow tract velocity (Figure 5-7c and Table 5-3). In 
wild-type zebrafish, color Doppler echocardiography shows a predictable flow pattern of 
inflow from the atrium into the ventricle (red) and outflow from the ventricle into the 
bulbus arteriosus (blue; Figure 5-7c). Heterozygote and homozygote robo4∆7 mutant fish 
displayed regurgitation of blood through the bulboventricular valve, as seen by aberrant 
flow via color Doppler (blue outflow immediately preceded by red backflow) and PW 
Doppler (negative outflow immediately preceded by positive backflow) (Figure 5-7c). 
Histological analysis demonstrated mutant fish have increased trabeculation of the apex 
of the ventricle as seen by H&E staining (Figure 5-7e). Masson’s trichome stain revealed 
increased collagen (blue) in the bulbus arteriosus of mutant fish compared to wild-type 
fish, suggestive of elastin degradation and reduced integrity of the bulbus arteriosus (5-
7e). In contrast, only four of 45 wild-type (AB and clutch mates) (8.9%) displayed any 
abnormal flow patterns of regurgitation/turbulence (Figure 5-7d). These data are 
statistically significant (P < 0.05). Thus, in zebrafish, loss-of-function mutations in robo4 
result in haploinsufficiency with incomplete penetrance for aberrant cardiac structure and 
function. 
 
5.2.3 Robo4 knockout mice show aberrant heart function 
 We next examined the effect of loss of ROBO4 function in mice using the 
Robo4tm1Lex model, which lacks exons 1 through 3. Robo4 transcripts were not detected in 
homozygous Robo4tm1Lex/tm1Lex mice via qRT-PCR (Figure 5-9a). None of the evaluated 
heterozygotes (Robo4tm1Lex/+) presented with any structural or functional abnormality. 
Homozygous Robo4tm1Lex/tm1Lex knockout mice exhibited a complex cardiovascular 
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phenotype that includes a combination of aortic valve thickening with or without BAV, 
aortic valve stenosis and/or regurgitation and/or AscAA. In general, these phenotypes 
were observed with low penetrance and male predominance. Overall, at 20 weeks of age, 
5/28 (17.9%) male and 2/18 (11.1%) female Robo4tm1Lex/tm1Lex mice were affected 
compared to 0/22 (0%) and 0/19 (0%) Robo4+/+ males and females, respectively (P < 
0.01; Figure 5-10). Additionally, one mouse with aortic regurgitation presented with a 
quadricuspid aortic valve (Figure 5-9b). 
 
5.2.4 Generation of a mutant mouse with splice site mutation from Family 1 
 We next sought to evaluate the in vivo consequence of the splice mutation 
(c.2056+1G>T) that we had observed in Family 1 by establishing a knock-in mouse line 
harboring a mutation (Robo4Skip13) at the splice donor site in intron 13 of Robo4 
(c.2089+1G>T) (Figure 5-11a). Sanger sequencing of cDNA amplicons spanning exons 
11-14 using mRNA derived from the ascending aorta of targeted animals revealed either 
in-frame skipping of exon 13 (Exons 12/14) or inclusion of exon 13 with activation of a 
cryptic splice donor in intron 13 (Figure 11b, c). Using TaqMan™ probes specific to 
individual exons or splice junctions we determined that wild-type mice show 100% 
normal splicing (Exons 12/13/14). Representation of Exons 12/13/14, Exons 
12/13+Intron 13 and Exons 12/14 transcripts was ~50%, 28% and 22% or ~0%, 55% and 
45% in Robo4+/Skip13 or Robo4Skip13/Skip13 animals, respectively (Figure 11d). We conclude 
that the Robo4Skip13 mutation alters pre-mRNA splicing with significant representation of 




5.2.5 Mice with the Robo4 splice site mutation show abnormal heart function 
 Like the knockout mice, Robo4Skip13 mice presented with an incompletely 
penetrant complex cardiovascular phenotype that included aortic valve defects and aortic 
valve dysfunction and AscAA. At 20 weeks, 1/31 (3.2%) Robo4Skip13/+ and 4/35 (11.4%) 




 This study demonstrates that heterozygous mutations in ROBO4 are sufficient to 
cause a nonsyndromic presentation of BAV/AscAA. The distribution of expression of 
ROBO4 in both the developing valve and the ascending aorta is consistent with the view 
that BAV and aortic aneurysm present as independent primary manifestations of the same 
underlying gene defect, a concept further supported by the presence of either 
BAV/AscAA, isolated BAV, or isolated AscAA in family members segregating the same 
ROBO4 mutation. This study highlights many obstacles in the elucidation of etiologies 
for BAV/AscA. These include a relatively low frequency for involvement of any specific 
disease gene (also evident for NOTCH1 and SMAD6), extreme locus heterogeneity, 
functional redundancy within relevant pathways, low penetrance with sex bias, and 
finally, the lack of signature for loss-of-function intolerance which is likely related to 
both the penetrance issue and to later onset of the phenotype and hence minimal, if any, 
impact on reproductive fitness. This study focuses attention on endothelial cell biology in 
BAV/AscAA, with impairment of barrier function and/or dysregulation of mesenchymal 
transition potentially contributing to disease expression. Interestingly, prior work has 
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suggested descriptive association between BAV/AscAA and an EnMT-like phenotype in 
the aortic wall (Maleki et al., 2016) and decreased mesenchymal potential of endothelial 
cells derived from such patients (Kostina et al., 2016), but neither study had defined the 
etiology or mechanism for these findings. Given prior data that link NOTCH signaling, 
enhancement of TGF-β, bone morphogenetic protein signaling, or suppression of 
signaling by SMAD6 to the induction of EnMT (Gonzalez & Medici, 2014), our findings 
provide further incentive to interrogate altered mesenchymal transition as a pathogenic 





5.4.1 Study participants. Affected individuals were recruited from the Connective Tissue 
Clinic at Johns Hopkins Hospital (H.C.D.), Duke University (G.C.H.), Radboud 
University Hospital/Antwerp University Hospital (B.L.L.), Centre Hospitalier 
Universitaire Sainte-Justine (G.A.), Karolinska University Hospital (P.E.), University of 
Luebeck (S.A.M.), Sickkids Hospital (S.M.), and Erasmus University Medical Center 
(M.W.). All skin biopsies and research protocols were collected in compliance with the 
Institutional Review Board at each respective institution after informed consent was 
obtained. Echocardiograms were performed and interpreted as previously described 
(Brooke et al., 2008). 
 
5.4.2 Whole exome sequencing. Genomic DNA was extracted from peripheral blood 
lymphocytes using standard protocols. DNA fragmentation was performed using a 
Covaris S2 system, and exon capture was performed using the Agilent SureSelect 38 Mb 
Human All Exon Target Enrichment system. DNA sequencing was performed on an 
Illumina Genome Analyzer IIx instrument with using standard protocols for 75 base pair 
paired-end runs. 
 
5.4.3 Bioinformatics analysis. Reads were mapped to the human reference genome 
(UCSC hg19) using the Burrows-Wheeler Aligner (BWA) and a variant list created using 
SAMtools, which were annotated using ANNOVAR (Li et al., 2009; Li & Durbin, 2009; 
K. Wang, Li, & Hakonarson, 2010). Local realignment and recalibration of base call 
quality scores was performed using the Genome Analysis Toolkit (GATK) (DePristo et 
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al., 2011; McKenna et al., 2010). Duplicates were identified using Picard. We selected 
for rare variants (dbSNP, exome variant server, ExAC) and focused only on exonic non-
synonymous, splice-site and insertion and/or deletion (indel) variants. Variants were 
viewed directly using the Integrated Genome Viewer (IGV) and excluded if reads were 
only present in one direction, if ambiguously mapped reads were present, or if an indel 
occurred within 3 base pairs of the end of the read (Robinson et al., 2011). 
 
5.4.4 Mutation validation and Sanger sequencing of candidate genes. Bidirectional 
Sanger DNA sequencing assays were performed using primers designed 60–120 base 
pairs from the variants or intron-exon boundaries to confirm candidate variants or 
sequence candidate genes. PCR was performed using a DNA Engine Dyad thermal cycler 
(Bio-Rad). Phusion Flash High Fidelity PCR Master Mix was used in accordance with 
the manufacturer's instructions for each primer set (Thermo Scientific). Cycle sequencing 
was performed using the BigDye Terminator v3.1 kit and an ABI 3730xl DNA Analyzer 
in accordance with the manufacturer's instructions (Life Technologies). Samples were 
purified using the QIAquick PCR Purification kit (Qiagen). 
 
5.4.5 Targeted sequencing. Enrichment for all exons of ROBO4, including ±10 
nucleotides of adjacent intronic sequences, was performed with a custom Haloplex target 
enrichment kit per instructions of the manufacturer (Agilent Technologies, USA). Probe 
design covered a theoretical 99.7% of the complete target region. Pooled samples were 
sequenced either on a HiSeq 2500 (Illumina, USA) with 2x150 base pair reads or on a 




5.4.6 Cell culture and transfection. Primary human dermal fibroblasts were derived from 
forearm skin biopsies from one control individual, a control cell line (ATCC), or a single 
proband. Cells were cultured in DMEM supplemented with 10% FBS in the presence of 
antibiotics and were passaged at confluence. Human aortic endothelial cells (HAEC) 
(Promocell, Heidelberg) were cultured in EGM2 BulletKi (Lonza, CC-3156/CC-4176) 
and used for experiments at P2-P4. For transfection experiments, cells were seeded at 60-
70% confluence. ROBO4 constructs were mixed with Lipofectamine 3000 (Invitrogen), 
diluted in EGM2 (without antibiotics) (for constructs, see Table 5-4), and treated for 24 
hours. HAEC media was then replaced and allowed to culture for an additional 48 hours. 
Transfection efficiency was measured via qRT-PCR and immunofluorescence. 
 
5.4.7 RNA isolation and qRT-PCR. For human and mice samples, RNA extractions were 
performed using a Qiagen total RNA purification kit (Qiagen) and RNA was reverse 
transcribed to cDNA using the SuperScript III RT-PCR kit with oligo(dT) primer 
(Invitrogen). Real-time PCR experiments were conducted using the FAM-MGB PCR 
system (Applied Biosystems) on QuantStudio 7 Real-Time ABI 384 cycler, with 40 
cycles per sample. Primers were normalized to 18S or GAPDH. The following pre-
validated probes were used for mRNA analysis: H200219408_m1 (Robo4), 
Hs01551861_m1 (TJP1), Hs00901463_m1 (CDH5), Hs00426835_g1 (ACTA2), 
Hs03003631_g1 (18S), and Hs02758991_g1 (GAPDH) (Life technologies). For 
zebrafish, RNA extracts were prepared from isolated wild-type or robo4 knockout adult 
hearts using RNA TRIzol (Ambion) and cDNA was synthesized using SuperScript III 
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Reverse Transcriptase kit (ThermoFisher Scientific). Two sets of specific primers 
spanning the junctions of exons 9 and 10 and of exons 16 and 17 were designed (see 
Table 5-5). All qRT-PCR data was obtained using the ViiA 7 Real-Time PCR System 
(Applied Biosystems) and SYBR Green PCR Mix (ThermoFisher). 
 
5.4.8 Antibody staining. Samples were fixed in 4% paraformaldehyde overnight at 4°C. 
Samples were then washed for 15 minutes on a rocker 3 times with PBS, permeabilized 
with 0.2% Triton-X 100 (VWR International, Radnor, PA) for 10 minutes, and washed 
another 3 times with PBS. Samples were incubated overnight at 4°C in a 1% BSA 
(Rockland Immunochemicals) blocking solution followed by another 4°C overnight 
incubation with ROBO4 (Abcam, ab103674), ROBO4 (Santa Cruz, sc-46497), CD31 
(Biocare Medical, CM303A), PECAM1 (Santa Cruz, sc-1506), CDH5 (Santa Cruz, sc-
28644), TJP1 (Santa Cruz, sc-8146), ACTA2 (Abcam, ab7817), or ALB (Santa Cruz, sc-
46293). After 3 washes for 15 minutes with PBS, samples were exposed to Alexa Fluor 
488 or 568 conjugated (Invitrogen), species-specific secondary antibodies at 1:100 in 1% 
BSA for 2 hours at room temperature. Three more washes with PBS for 15 minutes were 
followed by incubation with either DRAQ5 (far-red) nuclear stain or DAPI (UV) nuclear 
stain (Enzo Life Sciences) at 1:1000. 
 
5.4.9 Permeability assay. Permeability assays were performed as described previously 
(Anderl, Ma, & Armstrong, n.d.). HAECs were utilized at or before passage six. Cells 
were detached using 0.05% trypsin-EDTA, pelleted, then re-suspended in a growth 
medium to a concentration of 0.5-1X at 106 cells/mL. Dry collagen pre-coated porous 
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inserts were rehydrated for 15 minutes in a growth medium prior to cell seeding (1.0um 
pores, EMD Millipore). HAECs were seeded in 200 µL of growth medium per 24 well 
insert. 500 µL were added to each receiver plate well. HAECs were cultured in a 
37°C/5% CO2 tissue culture incubator for 72 hours to allow for a monolayer formation. 
Following endothelial monolayer formation, growth medium was carefully removed. 
This was replaced with medium containing different ROBO4 constructs (see Table 5-4). 
Samples were returned to 37°C incubation for 24 hours. Afterwards, the treatment 
medium was carefully removed. A high molecular weight FITC-dextran solution 
(40kDA) was created by 1:40 dilution in a growth medium and added at 150 µL. Growth 
medium was added to each receiver plate well at 500 µL (24-well). The FITC-dextran 
permeated the monolayers for 2 hours. The inserts were removed from the receiver wells 
to stop permeation. The medium in the receiver wells was then thoroughly mixed and 100 
µL was removed from each well to a black 96-well opaque plate for fluorescence 
measurement. Permeability was quantified on a Synergy-II fluorescent plate reader 
(Biotek) via fluorescence at 485nm excitation/535nm emission wavelengths (1 second 
fluorescent count time). The endothelial monolayer was stained after completion of 
FITC-dextran permeability testing for subsequent confocal imaging. 
 
5.4.10 Cell morphology assay. Cell shape was calculated as previously described using 
ImageJ (https://imagej.nih.gov/ij/plugins/circularity.html) (Gould, Sinha, et al., 2012). 
Cell shape changes were automatically tracked over subsequent images, and quantified as 
a cell circularity index (CI = 4*Pi*(Area/Perimeter2)). A circularity value of 1.0 indicates 
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a perfect circle. As the value approaches 0.0, it indicates an increasingly elongated 
polygon. 
 
5.4.11 Endothelial aggregate invasion assay. For invasion assays, cells were re-
suspended in culture media and allowed to aggregate overnight in hanging drop culture 
(20  µL; 20,000  cells). The aggregates were then placed on the surface of neutralized type 
I collagen hydrogels (1.5  mg/mL) as previously described (Chiu, Norris, Mahler, 
Recknagel, & Butcher, 2010) and allowed to adhere for 2  hours before adding treatments. 
Cultures were then transfected for 24 hours with the ROBO4 constructs (see Table 5-4) 
and maintained for another 72 hours. Cell invasion was quantified manually at a 50-µm 
depth into the gel and normalized to control. 
 
5.4.12 Scratch assay. Migratory ability was tested as described previously (Liang, Park, 
& Guan, 2007). Briefly, cells were cultured to confluency and then transfected for 24 
hours with the ROBO4 constructs. A scratch was then introduced using a 200-µl pipette 
tip. The cells were then incubated at 37°C and observed at 24 hours. Differences in filling 
in the scratch were observed to establish the capability of cellular migration. 
 
5.4.13 Proliferation assay. 5-bromo-2′-deoxyuridine (BrdU) incorporation was used to 
detect proliferating cells as described previously (Gould, Chin, et al., 2012). Cultures 
were transfected for 24 hours with the ROBO4 constructs (see Table 5-4). BrdU labeling 
reagent (Invitrogen) was added to the culture media for 12 hours after treatment. After 24 
hours, cells were fixed and targeted with a monoclonal Anti-BrdU Alexa Fluor 488 
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conjugate (PRB-1, Invitrogen) while total DNA was counterstained using a DAPI dye. 
Positive fluorescent areas for each cell were measured using ImageJ and normalized by 
cell nuclei. 
 
5.4.14 Zebrafish and mouse maintenance. Adult AB and robo4∆7 mutant zebrafish lines 
were maintained in system water according to standard methods (Westerfield, 2007). 
Mice were housed in the Johns Hopkins University School of Medicine East Baltimore 
campus. All strains were maintained on a mixed C57BL/6J and F129/SVE background. 
All zebrafish and mice upkeep and experimental procedures were in accordance with the 
ethical permits set by the Johns Hopkins Institutional Animal Care and Use Committee. 
 
5.4.15 Generation of robo4 knockout line by CRISPR/Cas9. We designed a single guide 
RNA (gRNA, see sequences in Table 5-5) to target the robo4 gene (gRNArobo4), using 
ZiFit (Sander et al., 2010; Sander, Zaback, Joung, Voytas, & Dobbs, 2007). Cas9 RNA 
was synthesized from linearized pCS2-nls-zCas9-nls (AddGene, no. 47929) (Jao, Wente, 
& Chen, 2013). We injected 100 ng/nL of gRNA and 300 ng of Cas9 in a 5-µL solution 
into 1-cell wild-type (AB) zebrafish embryos and raised them to maturity (F0). To 
identify fish capable of germline transmission, we crossed F0 males with AB females. 
Germline transmission was confirmed by Surveyor Assay (IDT) in pooled F1 embryos (n 
= 50) followed by Sanger sequencing. Heterozygous F1 adults with the same seven base 
pair deletion were inbred to establish the line (robo4jh176). All subsequent generations 




5.4.16 Robo4 knockout mice and generation of Robo4 knock-in mice. Robo4tm1Lex 
knockout mice were purchased through the mutant mouse resource and research centers 
supported by the NIH (MGI:5007309, Lexicon Pharmaceuticals). The mice were bred in 
a heterozygous state on a mixed background of 129S5/SvEvBrd and C57BL6/J. To 
generate Robo4 knock-in mice, we targeted the Robo4 locus using CRISPR/Cas9. Two 
single-guide RNA (sgRNA) sequences (see Table 5-6) were designed to target exon 13 of 
Robo4 (NC_000074.5) using a gRNA CRISPR design tool (http://crispr.technology/) 
(Jaskula-Ranga & Zack, 2016). Neither gRNA was predicted to have any off-target 
effects. These oligonucleotides were cloned into a pX459 plasmid (Ran et al., 2013) 
(Addgene, no. 48139) and appended with a T7 promoter. The sgRNA was transcribed in 
vitro. The homology directed repair (HDR) template was purchased as a 4nm Ultramer 
(IDT, see Table 5-6). The sgRNA, Cas9 (TriLink BioTechnologies), and HDR were co-
injected into C57BL/6J zygotes (Johns Hopkins University Transgenic Core). Pups (n = 
41) were screened for locus editing by Sanger sequencing (IDT, see Table 5-6). Mice 
(Robo4Skip13) were subsequently genotyped by Sanger sequencing (271 base pair 
amplicon). Mice were then crossed to a mixed background (129S5/SvEvBrd and 
C57BL6). 
 
5.4.17 Zebrafish and Mice Echocardiography. For zebrafish, we used the Vevo 2100 
Imaging System equipped with a 70 MHz ultrasound transducer (VisualSonics®, 
Toronto, ON, Canada). The zebrafish were anesthetized by placing the fish into a plastic 
cup filled with 100 ml of 168 µg/ml MS-222 (Tricaine methanesulfonate, Fluka 
Analytical). For mice, echocardiograms were undertaken on awake, unsedated mice using 
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the Vevo 2100 Imaging System (VisualSonics®, Toronto, ON, Canada) and a 40 MHz 
transducer. Echocardiographic recordings for the mice were taken using a parasternal 
long-axis or sagittal short axis view; 3 independent measurements of the maximal internal 
dimension at the sinus of Valsalva and ascending aorta were made and averaged. All data 
acquisition and measurements for mice and zebrafish were performed blinded to the 
genotype. 
 
5.4.18 Statistical analysis. For experiments including multiple comparisons, P values 
refer to one-way ANOVA followed by Tukey’s post-hoc test. For experiments including 
only one comparison, P values refer to unpaired two-tailed Student’s t-test, two-tailed 
Welch’s t-test, or two- or one-tailed Fisher’s exact test. P values less than 0.05 were 













history ExAC CADD 
BAV/AscAA c.C190T p.Arg64Cys 63 69 IG-L 1 L-R Yes 19/98998 21.6 
BAV/AscAA 
c.C190T 
p.Arg64Cys 312 260 IG-L 1 L-R N/A 19/98998 21.6 
BAV/AscAA 
c.G238A 
p.Ala95Thr 7 6 IG-L 1 R-N No 5/117304 6.42 
BAV/AscAA 
c.C695T 
p.Thr232Met 42 36 / R-L Yes 10/121068 19.56 
BAV/AscAA 
c.T740C 
p.Val247Ala 1204 1187 / L-R N/A 1/121370 10.5 
BAV/AscAA 
c.A839C 
p.Tyr280Ser 590 469 FN1 R-N N/A 5/117546 22 
BAV/AscAA 
c.T1233A 
p.His411Gln 31 30 FN2 R-N Yes Absent 0.002 
Control 
c.A1529T 
p.Asp510Val 69 51 / N/A N/A Absent 11.6 
BAV/AscAA 
c.1601_1614del 
p.Gly534Glufs*49 124 114 / N/A Yes Absent N/A 
BAV/AscAA 
c.C1702T 
p.Arg568Ter 43 49 / R-L No 12/120920 N/A 
BAV/AscAA 
c.G1864C 
p.Asp622His 767 721 / L-R N/A 4/110004 21.3 
BAV/AscAA 
c.G1864C 
p.Asp622His 1300 1118 / L-R No 4/110004 21.3 





195 173 / R-N N/A Absent 16.7 
 
Table 5-1. ROBO4 mutations are more frequent in cases than in controls. In the study, 
13/736 (1.77%) of BAV/AscAA individuals were heterozygous for a rare and deleterious 
(MAF<0.1% and CADD>20 or MAF<0.01%) compared to 1/376 controls (0.27%). 
These data suggest enrichment for deleterious ROBO4 variants in the patient cohort using 
a strict a priori filtering constraints (Fisher’s exact test, two-tailed P-value, n = 736 cases, 









Table 5-2. robo4 mutant embryos survive in Mendelian ratios through gastrulation. 
Embryos were genotyped at 24 hours post-fertilization (h.p.f.) to confirm all genotypes 
survived through gastrulation at Mendelian ratios (n = 106, P = 0.8433, chi-squared test). 
 
  
Genotype Percentage at 24 h.p.f. 
robo4+/+ 26.42% (n=28) 
robo4∆7/+ 50.94% (n=54) 




Parameters and Measurements Mean for wild-type  Mean for robo4∆7  P-value 
AV Measurements    
Early (E) Diastolic Filling (mm/s) 26.9 27.8 0.23 
Late (A) Diastolic Filling (mm/s) 59.4 65.8 0.28 
E/A 0.34 0.31 0.46 
AV Mean Velocity (mm/s) 34.3 41.2 0.80 
AV Peak Velocity (mm/s)  75.8 93.6 0.32 
Velocity Time Integral (mm) 7.6 8.7 0.39 
    
BV Measurements    
Heart Rate (bpm) 95 92.1 0.25 
BV Mean Velocity (mm/s) 49.4 57.84 0.031 
BV Peak Velocity (mm/s) 77.7 91.9 0.046 
Velocity Time Integral (mm) 10.0 11.8 0.03 
Ventricular Ejection Time (ms) 171.1 171.9  0.97 
    
Ventricular and BA Measurements    
Systolic Area (mm2) 0.30 0.42 0.34 
Diastolic Area (mm2) 0.41 0.58 0.14 
Systolic Volume (mm3) 0.12 0.20 0.29 
Diastolic Volume (mm3) 0.19 0.35 0.13 
BA Diameter (mm) 0.52 0.58 0.59 
Stroke Volume (mm3) 0.071 0.14 0.15 
Cardiac Output (mm3/min) 6.4 12.4 0.14 
 
Table 5-3. Parameters and measurements for wild-type and robo4∆7 mutants 
(heterozygotes and homozygotes). Comparison of physical parameters or measurements 
via echocardiography of robo4∆7 mutants without severe blood flow turbulence and wild-
type fish (clutch mates or AB) determined significant differences between the two groups 
of fish (bolded). A linear mixed model estimated the effect of group on mutation status. 
Age, sex, body size parameters, and type were included as covariates with date of 
echocardiography as a random effect: lmer(trait) ~ group + type + body weight + body 
length + body width + age + sex + (1 | date of echo) (n = 82 total; 37 robo4∆7 mutants, 45 
wild-type or AB fish). All statistical analyses were implemented in R version 3.2.3. AV: 
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Name (Abbreviation) Construct  
Control GFP plasmid (co-plasmid) pCMV6-AC-GFP  
(Origene, PS100010)  
Control siRNAs (co-siRNA) siGENOME Non-Targeting siRNA Pool  
(Dharmacon, D-001206-13-50) 
Global ROBO4 knockdown (siRNA) siGENOME-ROBO4  
(Dharmacon, M-015216-00-0005) 




Targeted ROBO4 knockdown of 







Overexpression of ROBO4 cDNA 
plasmid without exon 13 (OE-SS) 
ROBO4-GFP-pCMV6-AC-GFP 
(BLUE HERON, CUSTOM) 
Overexpression of ROBO4 cDNA 
plasmid with p.Arg64Cys (OE-R64C) 
ROBO4-GFP-pCMV6-AC-GFP 
(BLUE HERON, CUSTOM) 
 
Table 5-4. ROBO4 constructs used in functional studies in cell culture and TaqMan™ 





robo4 primer Forward Reverse 
1 CCAAACAACAAGGCCAAAAC GCACTCCCAAAGAGTGGTCT 
2 AACCCAGATCACAGTCTGCA TACAAGAAGCTGTGCACTGG 
3 TATCAGGTGTGGTGTGTGGA TATGGATCGCTCTGGACACC 

















Table 5-6. List of primers and oligonucleotide sequences used in the mice study. 
  
Robo4 Primer Forward Reverse 
1 CCCTTCTAGAATTGCACCAAGC ACGGATTCCAACCTGCTCAG 

















Figure 5-1. Identification of ROBO4 variants segregating in families with bicuspid aortic 
valve and aortic aneurysms. (a) In this large family, eight individuals showed AoRA with 
or without DAscAA and two had associated BAV. Whole exome sequencing (WES) 
revealed segregation of a heterozygous obligate splice site mutation (c.2056+1G>T) in a 
multigenerational family. (b) cDNA amplicons spanning exons 11-14 were analyzed 
from patient (proband 1.II:4) and control fibroblasts. Sanger sequencing confirmed 
skipping of exon 13 (108 base pair). (c) A missense mutation (p.Arg64Cys) was observed 
in a small family. The missense mutation resides at the Ig-like C2-type-1 (extracellular 
domain). (d) Sequencing of 736 individuals with BAV/TAA and 376 controls. Thirteen 
rare mutations (MAF<0.1% with CADD>20 or MAF<0.01%) were identified in 736 
patients and one in 376 controls. AscAA: ascending aortic aneurysm, BAV: bicuspid 
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aortic valve, AoRA: aortic root aneurysm, AVS: aortic valve stenosis, ASD: atrial septal 















Figure 5-2. (a) Sanger sequencing verification of the heterozygous obligate splice site 
mutation (c.2056+1G>T) in Family 1. (b) H&E stain of the affected patient (1:II:1) aortic 





















Figure 5-3. Evaluation of ascending aortic aneurysm tissue resected from patient 1.II:1, 
compared to an age- and sex-matched control. (a) Immunofluorescent staining of CD31 
(green), ROBO4 (red), and DAPI (blue) at the intima-media interface. Arrows indicate 
ROBO4+ cells deep within the aortic media. (b) Immunofluorescent staining of ⍺-SMA 
(green), ROBO4 (red), and DAPI (blue) at the intima-media interface. (c) 
Immunofluorescent staining of CD31 (green), ROBO4 (red), and DAPI (blue) at the 
endothelial layer. (d) Immunofluorescent staining of albumin (red) and DAPI (blue) at 
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the luminal surface. (e) Histological staining (H&E, Masson’s, and VVG) of patient and 

















Figure 5-4. ROBO4 mutant alleles impair endothelial barrier function. (a) HAECs were 
transfected with either co-plasmid (control GFP plasmid), co-siRNA (control siRNA), 
OE-WT (overexpression of ROBO4 wild-type plasmid), siRNA (global ROBO4 
knockdown), siRNA-Ex13 (ROBO4 knockdown through targeting of exon 13), OE-SS 
(overexpression of ROBO4 cDNA plasmid without exon 13), SS-alone (overexpression 
of ROBO4 cDNA plasmid without exon 13 plus silencing of endogenous ROBO4 using 
siRNA targeting exon 13), OE-R64C (overexpression of ROBO4 cDNA plasmid with 
p.Arg64Cys) and ROBO4 mRNA expression was quantified. (b) HAECs were cultured to 
confluency and a dextran permeability assay was used to assess the integrity of the 
endothelial barrier. Error bars show ± SE, n = 6. Asterisks signify significant differences 
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per one-way ANOVA with Tukey’s Post-hoc, *P < 0.05, **P < 0.01. (c) 
Immunofluorescent staining of VE-cadherin (green), tight junction protein ZO-1 (red), 
and DAPI (blue). TJP1 (encoding tight junction protein ZO-1) expression and CDH5 
(encoding VE-cadherin) expression were analyzed via qRT-PCR. For both a and c, error 
bars show ±SD, n = 6. Asterisks signify significant differences per a one-way ANOVA 



















Figure 5-5. Cellular phenotypes observed in HAECs transfected with ROBO4 mutant 
alleles or siRNA to silence ROBO4 expression. (a) HAECs were transfected with either 
co-plasmid (control GFP plasmid), co-siRNA (control siRNAs), OE-WT (overexpression 
of ROBO4 wild-type plasmid), siRNA (global ROBO4 knockdown), siRNA-Ex13 
(ROBO4 knockdown through targeting of exon 13), OE-SS (overexpression of ROBO4 
cDNA plasmid without exon 13), SS-alone (overexpression of ROBO4 cDNA plasmid 
without exon 13 plus silencing of endogenous ROBO4 using siRNA targeting exon 13), 
OE-R64C (overexpression of ROBO4 cDNA plasmid with p.Arg64Cys) and mRNA 
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expression levels for ACTA2 (encoding ⍺-smooth muscle actin; ⍺-SMA) were quantified 
via qRT-PCR and immunofluorescence, respectively. Error bars show ± SD, n = 6. 
Asterisks signify significant differences per a one-way ANOVA with Tukey’s post-hoc, * 
P < 0.05, ** P < 0.01. (b) Cellular morphology was captured via bright-field microscopy 
and quantified as a circularity index using ImageJ, n = >200 cells were assessed per 
condition. (c) Endothelial invasion was assessed using an endothelial aggregate invasion 
assay on collagen gels. (d) Migration and proliferation were measured using a scratch 
assay and 5-bromo-2′-deoxyuridine (BrDU) proliferation assay, respectively. For b, c, d, 
error bars show ± SE, n = 3. Asterisks signify significant differences per a one-way 
















Figure 5-6. Immunofluorescent staining for ROBO4 in the developing murine outflow 
tract (OFT) and human adult ascending aorta. (a) Murine ROBO4 expression in the 
endothelial layer of the embryonic endocardial OFT cushions and the primordial aortic 
valve leaflets at E11.5 and E17, respectively. (b) Murine ROBO4 expression in the 
endothelium of the OFT (E17) and ascending aorta (5wk). (c) Human control ROBO4 


















Figure 5-7. robo4 deficiency results in aberrant blood flow in the adult zebrafish. (a) A 
mutant line for robo4 was generated using CRISPR/Cas9. A seven-base pair deletion was 
induced in exon 6 (robo4∆7). (b) robo4 expression was analyzed by qRT-PCR on 4 hearts 
per genotype and then averaged. Results are shown normalized to β-actin mRNA 
expression. Graph shows mean ±SE, n = 4 biological replicates per genotype run on the 
same plate. Asterisks signify significant differences per a two-tailed Welch’s t-test, * P < 
0.05; ** P < 0.01. (c) Representative color Doppler echocardiograms for wild-type 
zebrafish show blood flow during systole (blue) and during diastole (red). A 
representative pulsed wave Doppler image of a wild-type zebrafish shows normal flow 
pattern. Representative color Doppler echocardiograms for robo4∆7/∆7 mutant zebrafish 
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show blood flow during systole (blue) and regurgitation (red) during diastole from the 
bulbus arteriosus (BA) into the ventricle (V). A representative pulsed wave Doppler 
image of robo4∆7/∆7 zebrafish shows regurgitant flow through the ventriculo-bulbar valve 
(orange arrow). The white arrow marks normal flow through the ventriculo-bulbar valve. 
(d) Approximately 11/41 (26.8%) of robo4∆7 mutants (heterozygous and homozygous) 
exhibit aberrant echocardiograms with regurgitation or turbulence while only 4/45 
(8.88%) of wild-type fish showed this phenotype. Statistical differences calculated per a 
Fisher’s exact test, one-tailed P-value, *P = 0.028, P < 0.05 is considered statistically 
significant. (e) Histological staining (H&E and Masson’s trichrome) of the ventricle and 
















Figure 5-8. robo4 loss-of-function mutants do not show an overt embryonic phenotype. 
At all stages, mutants did not show gross cardiac, craniofacial, or trunk defects. h.p.f.: 













Figure 5-9. Phenotype data for Robo4tm1Lex knockout mice with AscAA. (a) Robo4 
mRNA expression, normalized to Gapdh, was analyzed by pooling 4 samples per 
genotype and performing qPCR. Error bars show ± SD, n = 4 per genotype pooled, one 
experiment. Asterisks signify statistical differences per a two-tailed Student’s t-test 
relative to control, * P < 0.05, ** P < 0.01. (b) H&E histology of a quadricuspid valve in 

















Figure 5-10. Robo4 knockout causes aortic valve defects and aortic aneurysm in mice. (a) 
Wild-type (Robo4+/+), heterozygous (Robo4+/tm1Lex), and knockout (Robo4tm1Lex/tm1Lex) 
mice were aged to 20 weeks and the cardiovascular phenotype was determined. Aortic 
dilatation was defined as a Z-score greater than two when compared to wild-type male 
mice by echocardiography. Statistical differences per a one-tailed Fisher’s exact test, n = 
112 total male and female mice, P < 0.05 was considered statistically significant. (b) 
Representative parasternal long axis and pulsed-wave Doppler images. Red arrows 
indicate a dilated segment of the ascending aorta. The yellow arrow shows increased 
velocity of outflow across the aortic valve during systole while the orange arrow shows 
regurgitant flow during diastole in a Robo4tm1Lex/tm1Lex mouse. (c) Gross and histological 
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examination of the aortic valve. Numbers refer to individual commissures. AscAA: 
ascending aortic aneurysm, AoRA: aortic root aneurysm, *abnormal aortic valve 
morphology including BAV, distal commissure fusion, leaflet thickening, or quadricuspid 
aortic valve among mutant mice with flow abnormalities by echocardiogram. 
Comparison is made to a representative sample of wild-type mice. **pure bicommissural 



















Figure 5-11. A knock-in line harboring a mutation (RoboSkip13) at the splice acceptor site 
in exon 13 (c.2089+1G>T). (a) Sanger sequencing of the splice site mutation. (b, c) In-
frame skipping of exon 13 (Ex12/14) or inclusion of exon 13 with activation of a cryptic 
splice donor in intron 13 that adds 15 base pairs to the mature mRNA (Ex12/13+15bp/14) 
that are predicted to add five extra amino acids between those encoded by exons 13 and 
14. (d) TaqMan™ probes were used to directly compared exon 12/13 and exon 2/3 
expression as this would provide a relative ratio of exon 13 skipping versus wild-type. 
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Error bars show ±SD, n = 4. Asterisks signify statistical differences per a one-way 
















Figure 5-12. Knock-in splice site mutation (c.2089+1G>T; Robo4Skip13) causes aortic 
valve defects and aortic aneurysm in mice. (a) Wild-type (Robo4+/+), heterozygous 
(Robo4+/Skip13), and homozygous (Robo4Skip13/Skip13) mice were aged to 20 weeks and the 
cardiovascular phenotype was determined. Aortic dilatation was defined as a Z-score 
greater than two when compared to wild-type male mice by echocardiography. 
Significant differences per a one-tailed Fisher’s exact test, n = 106 total male mice, P < 
0.05 was considered statistically significant. (b) Representative parasternal long axis and 
pulsed-wave Doppler images. Red arrows indicate a dilated segment of the aortic root. 
The yellow arrow shows increased velocity of outflow across the aortic valve during 
systole while the orange arrow shows regurgitant flow during diastole in a Robo4Skip13 
mouse. (c) Gross and histological examination of the aortic valve. Numbers refer to 
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individual commissures. AscAA: ascending aortic aneurysm, AoRA: aortic root 
aneurysm. *abnormal aortic valve morphology including BAV, distal commissure fusion, 
leaflet thickening, or quadricuspid aortic valve among mutant mice with flow 
abnormalities by echocardiogram. Comparison is made to a representative sample of 





Chapter 6: Conclusions 
	  
	   The heart is a pump. It has two main components: first is the structural 
component. Blood flows through the right atrium, to the right ventricle and into the 
pulmonary artery then to the lungs, where the blood becomes oxygenated. Blood then 
flows into the left atrium, to the left ventricle and into the aorta. The aorta is the structure 
that works as a capacitor to maintain blood flow through the body. Heart valves, between 
each of the four chambers, work to maintain this very specific blood flow pattern. 
Diseases that affect the structure are called congenital heart disease and affect 
approximately 1% of individuals. A specific congenital heart disease of interest in our 
laboratory is bicuspid aortic valve (BAV) and associated ascending aortic aneurysm 
(AscAA). The second component of the heart is electrical. In order to move blood 
through the heart, the heart contracts. An electrical pulse first contracts the atria and then 
the ventricles. This electrical pulse is commonly illustrated as a P wave, a QRS complex, 
and a T wave as seen in an electrocardiogram. Diseases that affect the conductance are 
arrhythmias, including sudden cardiac death and long QT syndrome.  
 In order to study these diseases, our laboratory is part of two larger groups 
studying bicuspid aortic valve and sudden cardiac death and arrhythmias. As part of these 
larger groups, genetic studies are performed using patient data and our laboratory 
specifically performs functional studies in vivo, using zebrafish. My thesis objectives 
were to first expand the functional analysis toolbox in zebrafish and thereby, facilitate the 
evaluation of cardiovascular phenotypes, including both structural and conductance 
issues. Next, I wanted to establish baseline measurements for wild-type zebrafish using 
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these tools (echocardiography and electrocardiography) as well as apply new models of 
analysis. Finally, I applied these techniques to determine the biological significance of 
candidate genes implicated in cardiac diseases including sudden cardiac death and 
bicuspid aortic valve. 
 Zebrafish are a great model organism with which to study cardiovascular 
malformations. First, they are cost-effective vertebrates. Zebrafish fertilize externally and 
they are transparent as embryos. Interestingly, they are not dependent on a fully 
functioning cardiovascular system until seven days post-fertilization, which allows us to 
cause cardiac malformations or disrupt the heart function, without lethality. Zebrafish 
have a two-chambered heart, which simplifies the heart system as well. Most importantly, 
however, the cardiac electrophysiology of zebrafish is remarkably similar to human 
cardiac electrophysiology (I. U S Leong et al., 2010).  
 In order to study the heart anatomy, we developed a new procedure to perform 
echocardiography in zebrafish. No other group has published with the resolution we can 
capture using a high-resolution transducer and using ultrasound gel directly on the fish. 
Incredibly, we are still able to keep the fish alive during these studies. In a longitudinal 
study on wild-type fish, we determined the normal echocardiographic measurements for 
wild-type fish of commonly used ages. These baseline measurements can be used as 
standards for all future studies on fish in the facility. 
 From these measurements, we determined the best and most accurate way to 
analyze the data. Echocardiographic studies in zebrafish fail to account for the size of the 
heart and for the fish generally (L. W. Wang et al., 2017). Wang et al. did look into 
adjusting for body mass index (BMI) or body surface area (BSA), but simply divided 
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each anatomical measurement by BMI or BSA. This does not accurately account or 
adjust for appropriate size measurements of the fish nor were any tests performed to 
determined whether BSA or BMI were better to use. It is common in humans studies to 
control for sex, age, and body size (Pettersen, Du, Skeens, & Humes, 2008; Roman, 
Devereux, Kramer-Fox, & O’Loughlin, 1989; Sluysmans, 2005). With our data, we 
performed a correlation analysis and saw that body size parameters are highly correlated 
(directly or anti-) with echocardiographic measurements. Thus measurements of zebrafish 
cardiac function and structure, captured by echocardiography, must be adjusted for body 
size parameters. The most accurate way to model this is with a linear mixed effects 
model, where sex, age, and body size parameters are fixed effects and date of 
echocardiography is a random effect. 
 In order to study the sudden cardiac death and arrhythmia candidate genes, we 
established an ECG protocol using the iWorx Zebrafish ECG Recording and Analysis 
System. Very few studies have been published on adult zebrafish ECG and most use a 
procedure that requires perfusion of the animal. The iWorx System allows us to perform 
surface ECG, keeping the fish alive and stable, with minimal interference in the normal 
conductance of the fish. We performed ECG analysis in parallel with the 
echocardiography study and captured normal measurements for wild-type fish in a 
longitudinal study. Similar to the echocardiography data, by correlation analysis, we 
determined that sex, age, and body size must be adjusted for in ECG studies. This has not 
been done previously. This linear mixed effects model includes sex, age, and body size 
parameters as fixed effects and date of ECG as a random effect. Together with the 
echocardiography data, this study provides a comprehensive analysis of wild-type 
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zebrafish at ages crucial to the zebrafish community and sets guidelines on all future 
studies, in our laboratory and others’. 
 We next applied this working pipeline for zebrafish cardiovascular phenotypes to 
two well-characterized models of arrhythmia and long QT syndrome for the gene, 
kcnh6a. The first long QT model is called kcnh6atb218. With our machine and our 
analysis, we did not detect any cardiac conductance defect in these mutant fish. 
Interestingly, we do see a 2:1 AV block in the embryos. This change in heart function 
between larval and adult stages is fascinating and is open for future investigation. By 
echocardiography, we saw no structural defects either. The second model is called 
kcnh6as290. This model had both prolonged QRS and QT intervals in adults, as shown in 
previous studies (Rima Arnaout et al., 2007). No embryonic phenotype was detected. By 
echocardiography, the mutant fish had a decreased velocity time integral through the AV 
valve, which could be caused by disruption in the contraction of the ventricle. The 
detection of arrhythmia in this model confirmed our abilities to perform ECG, 
echocardiography, and analyze mutant fish. 
 We then applied these methods to a novel candidate gene of interest for bicuspid 
aortic valve and aneurysm. ROBO4 encodes a factor known to contribute to endothelial 
performance. It is expressed in vascular endothelial cells and has been implicated in the 
regulation of angiogenesis and involved in endothelial cell barrier integrity. We found a 
total of 13 variants in cases of BAV with and without AscAA and one variant in controls 
(735 cases, and 376 controls). Cellular and molecular assays performed on patient and 
control cells demonstrated a fibroproliferative response in patient cells as well as a 
decreased endothelial layer barrier. These data fit with the hypothesis and we moved to in 
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vitro studies using zebrafish. We generated a line with a seven base pair deletion in exon 
six, which resulted in a loss-of-function allele. Mutant embryos showed no gross defects 
in cardiovascular development. However, about 27% percent of heterozyous and 
homozgyous adult fish combined showed blood flow regurgitation and turbulence in the 
outflow tract. Only four out of 45 wild-type fish showed a similar gross phenotype as 
detected by color Doppler. For all 86 fish, we also determined all capable 
echocardiographic measurements and parameters.	  We found that the blood flow velocity 
through the bulboventricular valve, which is analogous to the aortic valve, is significantly 
faster in robo4 mutant fish than wild-type fish. Faster flow through the aortic valve is a 
common sign of aortic stenosis and found commonly in patients with bicuspid aortic 
valve. This observation of a diseased state in the zebrafish was confirmed by histology. 
Data from the knockout mice are consistent with the zebrafish. These data together 
establish ROBO4 as a gene critical for the normal development and homeostasis of 
outflow tract and establish a robust system and protocols for functional validation of 
other candidate genes of BAV/AscAA including SEMA3C and SMAD6. 
 To conclude, I have established a working pipeline for phenotyping adult 
zebrafish heart using echocardiography and ECG. I gathered wild-type baseline 
measurements for the zebrafish in our facility at different ages typically used for study. I 
determined a linear mixed effects model of analysis to adjust for variation between 
zebrafish that can affect the analysis of data. These variants include sex, age, and body 
size parameters. These covariates must be adjusted for in echocardiography and ECG 
analysis in zebrafish. I have successfully generated a loss-of-function mutant zebrafish 
line for robo4. This model shows a turbulent and blood flow phenotype consistent with 
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the mouse model. Finally, this work sets the groundwork for future translational research 
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